Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Frederick Appelbaum

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Living Beings

Dogs

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
210
Storb, Rainer
111
Buckner, Dean
96
Deeg, Joachim
85
Bensinger, William
78
Anasetti, Claudio
68
Doney, Kristine
66
Clift, Reginald
62
Sanders, Jean
58
Martin, Paul
44
Schuening, Friedrich
40
Witherspoon, Robert
39
Press, Oliver
37
Thomas, ED
37
Chauncey, Thomas
36
Hansen, John

Sign-in to see all Coauthors

Publications

TOP 3
Delaney Colleen; Gutman Jonathan A; Appelbaum Frederick R
Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications.
Gutman Jonathan A; Leisenring Wendy; Appelbaum Frederick R; Woolfrey Ann E; Delaney Colleen
Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis.
Meshinchi Soheil; Appelbaum Frederick R
Structural and functional alterations of FLT3 in acute myeloid leukemia.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Frederick Appelbaum (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Delaney Colleen; Gutman Jonathan A; Appelbaum Frederick R
Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications.
British journal of haematology 2009;147(2):207-16.
2009: Gutman Jonathan A; Leisenring Wendy; Appelbaum Frederick R; Woolfrey Ann E; Delaney Colleen
Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1122-9.
2009: Meshinchi Soheil; Appelbaum Frederick R
Structural and functional alterations of FLT3 in acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(13):4263-9.
2009: Koreth John; Schlenk Richard; Kopecky Kenneth J; Honda Sumihisa; Sierra Jorge; Djulbegovic Benjamin J; Wadleigh Martha; DeAngelo Daniel J; Stone Richard M; Sakamaki Hisashi; Appelbaum Frederick R; Döhner Hartmut; Antin Joseph H; Soiffer Robert J; Cutler Corey
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.
JAMA : the journal of the American Medical Association 2009;301(22):2349-61.
2009: Carnevale-Schianca Fabrizio; Leisenring Wendy; Martin Paul J; Furlong Terry; Schoch Gary; Anasetti Claudio; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Kiem Hans-Peter; Storb Rainer; McDonald George B; Nash Richard A
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):749-56.
2009: Rotta Marcello; Storer Barry E; Sahebi Firoozeh; Shizuru Judith A; Bruno Benedetto; Lange Thoralf; Agura Edward D; McSweeney Peter A; Pulsipher Michael A; Hari Parameswaran; Maziarz Richard T; Chauncey Thomas R; Appelbaum Frederick R; Sorror Mohamed L; Bensinger William; Sandmaier Brenda M; Storb Rainer F; Maloney David G
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood 2009;113(14):3383-91.
2009: Mielcarek Marco; Storer Barry E; Boeckh Michael; Carpenter Paul A; McDonald George B; Deeg H Joachim; Nash Richard A; Flowers Mary E D; Doney Kristine; Lee Stephanie; Marr Kieren A; Furlong Terry; Storb Rainer; Appelbaum Frederick R; Martin Paul J
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Blood 2009;113(13):2888-94.
2009: Pagel John M; Matthews Dana C; Kenoyer Aimee; Hamlin Donald K; Wilbur Daniel S; Fisher Darrell R; Gopal Ajay K; Lin Yukang; Saganic Laura; Appelbaum Frederick R; Press Oliver W
Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia.
Cancer research 2009;69(1):185-92.
2009: Becker Pamela S; Kopecky Kenneth J; Wilks Adrianne N; Chien Sylvia; Harlan John M; Willman Cheryl L; Petersdorf Stephen H; Stirewalt Derek L; Papayannopoulou Thalia; Appelbaum Frederick R
Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.
Blood 2009;113(4):866-74.
2009: Sanders Jean E; Hoffmeister Paul A; Woolfrey Ann E; Carpenter Paul A; Storer Barry E; Storb Rainer F; Appelbaum Frederick R
Thyroid function following hematopoietic cell transplantation in children: 30 years' experience.
Blood 2009;113(2):306-8.
2008: Appelbaum Frederick R
What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)?
Best practice & research. Clinical haematology 2008;21(4):667-75.
2008: O'Donnell Margaret R; Appelbaum Frederick R; Coutre Steven E; Damon Lloyd E; Erba Harry P; Foran James; Lancet Jeffrey; Maness Lori J; Marcucci Guido; Maslak Peter G; Millenson Michael; Moore Joseph O; Ravandi Farhad; Schuening Friedrich; Shami Paul; Smith B Douglas; Stone Richard M; Tallman Martin S; Wang Eunice; White Frank L
Acute myeloid leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(10):962-93.
2008: Woolfrey Ann E; Malhotra Uma; Harrington Robert D; McNevin John; Manley Thomas J; Riddell Stanley R; Coombs Robert W; Appelbaum Frederick R; Corey Larry; Storb Rainer
Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.
Blood 2008;112(8):3484-7.
2008: Scott Bart L; Park J Y; Deeg H Joachim; Marr Kieren A; Boeckh Michael; Chauncey Thomas R; Appelbaum Frederick R; Storb Rainer; Storer Barry E
Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):799-806.
2008: Appelbaum Frederick R
Hematopoietic cell transplantation for non-Hodgkin's lymphoma: yesterday, today, and tomorrow.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):2927-9.
2008: Furlong Terry; Kiem Hans-Peter; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Flowers Mary E D; Mielcarek Marco; Nash Richard A; Storb Rainer; Martin Paul J
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(5):531-7.
2008: Walter Roland B; Boyle Kelli M; Appelbaum Frederick R; Bernstein Irwin D; Pagel John M
Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts.
Blood 2008;111(9):4813-6.
2008: Appelbaum Frederick R
Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).
Best practice & research. Clinical haematology 2008;21(1):85-92.
2007: Petersdorf Stephen H; Rankin Cathryn; Head David R; Terebelo Howard R; Willman Cheryl L; Balcerzak Stanley P; Karnad Anand B; Dakhil Shaker R; Appelbaum Frederick R
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500).
American journal of hematology 2007;82(12):1056-62.
2007: Appelbaum Frederick R
Hematopoietic-cell transplantation at 50.
The New England journal of medicine 2007;357(15):1472-5.
2007: Sorror Mohamed L; Sandmaier Brenda M; Storer Barry E; Maris Michael B; Baron Frédéric; Maloney David G; Scott Bart L; Deeg H Joachim; Appelbaum Frederick R; Storb Rainer
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4246-54.
2007: Riddell Stanley R; Appelbaum Frederick R
Graft-versus-host disease: a surge of developments.
PLoS medicine 2007;4(7):e198.
2007: DeAngelo Daniel J; Yu Daohai; Johnson Jeffrey L; Coutre Steven E; Stone Richard M; Stopeck Alison T; Gockerman Jon P; Mitchell Beverly S; Appelbaum Frederick R; Larson Richard A
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
Blood 2007;109(12):5136-42.
2007: Walter Roland B; Gooley Ted A; van der Velden Vincent H J; Loken Michael R; van Dongen Jacques J M; Flowers David A; Bernstein Irwin D; Appelbaum Frederick R
CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy.
Blood 2007;109(10):4168-70.
2007: Gopal Ajay K; Rajendran Joseph G; Gooley Ted A; Pagel John M; Fisher Darrell R; Petersdorf Stephen H; Maloney David G; Eary Janet F; Appelbaum Frederick R; Press Oliver W
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1396-402.
2007: Carpenter Paul A; Snyder David S; Flowers Mary E D; Sanders Jean E; Gooley Theodore A; Martin Paul J; Appelbaum Frederick R; Radich Jerald P
Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia.
Blood 2007;109(7):2791-3.
2007: Appelbaum Frederick R
Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remission.
Best practice & research. Clinical haematology 2007;20(1):67-75.
2007: Kerbauy Daniella M B; Gooley Theodore A; Sale George E; Flowers Mary E D; Doney Kristine C; Georges George E; Greene Joanne E; Linenberger Michael; Petersdorf Effie; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed; Stirewalt Derek L; Stewart F Marc; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):355-65.
2007: Appelbaum Frederick R; Rosenblum Daniel; Arceci Robert J; Carroll William L; Breitfeld Philip P; Forman Stephen J; Larson Richard A; Lee Stephanie J; Murphy Sharon B; O'Brien Susan; Radich Jerald; Scher Nancy S; Smith Franklin O; Stone Richard M; Tallman Martin S
End points to establish the efficacy of new agents in the treatment of acute leukemia.
Blood 2007;109(5):1810-6.
2007: Oehler Vivian G; Gooley Ted; Snyder David S; Johnston Laura; Lin Allen; Cummings Carrie C; Chu Su; Bhatia Ravi; Forman Stephen J; Negrin Robert S; Appelbaum Frederick R; Radich Jerald P
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia.
Blood 2007;109(4):1782-9.
2006: Appelbaum Frederick R; Kopecky Kenneth J; Tallman Martin S; Slovak Marilyn L; Gundacker Holly M; Kim Haesook T; Dewald Gordon W; Kantarjian Hagop M; Pierce Sherry R; Estey Elihu H
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations.
British journal of haematology 2006;135(2):165-73.
2006: Gopal Ajay K; Pagel John M; Rajendran Joseph G; Maloney David G; Appelbaum Frederick R; Sorror Mohamed L; Sandmaier Brenda M; Storb Rainer; Press Oliver W
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):697-702.
2006: Slovak M L; Gundacker H; Bloomfield C D; Dewald G; Appelbaum F R; Larson R A; Tallman M S; Bennett J M; Stirewalt D L; Meshinchi S; Willman C L; Ravindranath Y; Alonzo T A; Carroll A J; Raimondi S C; Heerema N A
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(7):1295-7.
2006: Wilson Carla S; Davidson George S; Martin Shawn B; Andries Erik; Potter Jeffrey; Harvey Richard; Ar Kerem; Xu Yuexian; Kopecky Kenneth J; Ankerst Donna P; Gundacker Holly; Slovak Marilyn L; Mosquera-Caro Monica; Chen I-Ming; Stirewalt Derek L; Murphy Maurice; Schultz Frederick A; Kang Huining; Wang Xuefei; Radich Jerald P; Appelbaum Frederick R; Atlas Susan R; Godwin John; Willman Cheryl L
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.
Blood 2006;108(2):685-96.
2006: Deeg H Joachim; Storer Barry E; Boeckh Michael; Martin Paul J; McCune Jeannine S; Myerson David; Heimfeld Shelly; Flowers Mary E; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Nash Richard A; O'Donnell Paul V; Radich Jerald P; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed L; Warren E Houston; Witherspoon Robert P; Woolfrey Ann; Appelbaum Frederick R; Storb Rainer
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):573-84.
2006: Appelbaum Frederick R; Gundacker Holly; Head David R; Slovak Marilyn L; Willman Cheryl L; Godwin John E; Anderson Jeanne E; Petersdorf Stephen H
Age and acute myeloid leukemia.
Blood 2006;107(9):3481-5.
2006: Pagel John M; Appelbaum Frederick R; Eary Janet F; Rajendran Joseph; Fisher Darrell R; Gooley Ted; Ruffner Katherine; Nemecek Eneida; Sickle Eileen; Durack Larry; Carreras Jeanette; Horowitz Mary M; Press Oliver W; Gopal Ajay K; Martin Paul J; Bernstein Irwin D; Matthews Dana C
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.
Blood 2006;107(5):2184-91.
2006: O'Donnell Margaret R; Appelbaum Frederick R; Baer Maria R; Byrd John C; Coutre Steven E; Damon Lloyd E; Erba Harry P; Estey Eli; Foran James; Lancet Jeffrey; Maness Lori J; Maslak Peter G; Millenson Michael; Moore Joseph O; Przepiorka Donna; Shami Paul; Smith B Douglas; Stone Richard M; Tallman Martin S
Acute myeloid leukemia clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(1):16-36.
2006: Zaucha Renata E; Buckner Dean C; Barnett Todd; Holmberg Leona A; Gooley Ted; Hooper Heather A; Maloney David G; Appelbaum Frederick; Bensinger William I
Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies.
International journal of radiation oncology, biology, physics 2006;64(1):227-34.
2006: Appelbaum Frederick R; Pearce S Frieda
Hematopoietic cell transplantation in first complete remission versus early relapse.
Best practice & research. Clinical haematology 2006;19(2):333-9.
2005: Hussein M A; Gundacker H; Head D R; Elias L; Foon K A; Boldt D H; Dobin S M; Dakhil S R; Budd G T; Appelbaum F R
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(11):1880-6.
2005: Walter Roland B; Pirga Jason L; Cronk Michelle R; Mayer Sasha; Appelbaum Frederick R; Banker Deborah E
PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism.
Blood 2005;106(10):3584-93.
2005: Larson Richard A; Sievers Eric L; Stadtmauer Edward A; Löwenberg Bob; Estey Elihu H; Dombret Hervé; Theobald Matthias; Voliotis Dimitris; Bennett John M; Richie Maria; Leopold Lance H; Berger Mark S; Sherman Matthew L; Loken Michael R; van Dongen Jacques J M; Bernstein Irwin D; Appelbaum Frederick R
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.
Cancer 2005;104(7):1442-52.
2005: Kerbauy Daniella M B; Chyou Faith; Gooley Ted; Sorror Mohamed L; Scott Bart; Pagel John M; Myerson David; Appelbaum Frederick R; Storb Rainer; Deeg H Joachim
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(9):713-20.
2005: Nash Richard A; Johnston Laura; Parker Pablo; McCune Jeannine S; Storer Barry; Slattery John T; Furlong Terry; Anasetti Claudio; Appelbaum Frederick R; Lloid Michele E; Deeg H Joachim; Kiem Hans-Peter; Martin Paul J; Schubert Mark M; Witherspoon Robert P; Forman Stephen J; Blume Karl G; Storb Rainer
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):495-505.
2005: Carpenter Paul A; Lowder James; Johnston Laura; Frangoul Haydar; Khoury Hanna; Parker Pablo; Jerome Keith R; McCune Jeannine S; Storer Barry; Martin Paul; Appelbaum Frederick; Abonour Rafat; Westervelt Peter; Anasetti Claudio
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(6):465-71.
2005: Wallen Herschel; Gooley Theodore A; Deeg H Joachim; Pagel John M; Press Oliver W; Appelbaum Frederick R; Storb Rainer; Gopal Ajay K
Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3439-46.
2005: Sanders Jean E; Im Ho Joon; Hoffmeister Paul A; Gooley Ted A; Woolfrey Ann E; Carpenter Paul A; Andrews Robert G; Bryant Eileen M; Appelbaum Frederick R
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.
Blood 2005;105(9):3749-56.
2005: Oehler Vivian G; Radich Jerald P; Storer Barry; Blume Karl G; Chauncey Thomas; Clift Reginald; Snyder David S; Forman Stephen J; Flowers Mary E D; Martin Paul; Guthrie Katherine A; Negrin Robert S; Appelbaum Frederick R; Bensinger William
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):85-92.
2005: Appelbaum F R
Dose intensity and the toxicity and efficacy of allogeneic hematopoietic cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(2):171-5.
2005: Flowers M E D; Traina F; Storer B; Maris M; Bethge W A; Carpenter P; Appelbaum F; Storb R; Sandmaier B M; Martin P J
Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning.
Bone marrow transplantation 2005;35(3):277-82.
2005: Sanders Jean E; Guthrie Katherine A; Hoffmeister Paul A; Woolfrey Ann E; Carpenter Paul A; Appelbaum Frederick R
Final adult height of patients who received hematopoietic cell transplantation in childhood.
Blood 2005;105(3):1348-54.
2005: Nemecek Eneida R; Hamlin Donald K; Fisher Darrell R; Krohn Kenneth A; Pagel John M; Appelbaum Frederick R; Press Oliver W; Matthews Dana C
Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):787-94.
2005: Tse William; Joachim Deeg H; Stirewalt Derek; Appelbaum Frederick R; Radich Jerald; Gooley Theodore
Increased AF1q gene expression in high-risk myelodysplastic syndrome.
British journal of haematology 2005;128(2):218-20.
2005: Scott Bart L; Storer Barry; Loken Michael R; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(1):65-73.
2004: Scott Bart; Deeg H Joachim; Storer Barry; Chauncey Thomas; Petersdorf Stephen; Slattery John; Appelbaum Frederick
Targeted busulfan and cyclophosphamide as compared to busulfan and TBI as preparative regimens for transplantation in patients with advanced MDS or transformation to AML.
Leukemia & lymphoma 2004;45(12):2409-17.
2004: Stewart Betty L; Storer Barry; Storek Jan; Deeg H Joachim; Storb Rainer; Hansen John A; Appelbaum Frederick R; Carpenter Paul A; Sanders Jean E; Kiem Hans-Peter; Nash Richard A; Petersdorf Effie W; Moravec Carina; Morton A James; Anasetti Claudio; Flowers Mary E D; Martin Paul J
Duration of immunosuppressive treatment for chronic graft-versus-host disease.
Blood 2004;104(12):3501-6.
2004: Deeg H Joachim; Jiang Peter Y Z; Holmberg Leona A; Scott Bart; Petersdorf Effie W; Appelbaum Frederick R
Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.
Leukemia research 2004;28(11):1177-80.
2004: Tse William; Meshinchi Soheil; Alonzo Todd A; Stirewalt Derek L; Gerbing Robert B; Woods William G; Appelbaum Frederick R; Radich Jerald P
Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia.
Blood 2004;104(10):3058-63.
2004: Banker Deborah E; Mayer Sasha J; Li Henry Y; Willman Cheryl L; Appelbaum Frederick R; Zager Richard A
Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells.
Blood 2004;104(6):1816-24.
2004: Martin Paul J; Pei Ji; Gooley Ted; Anasetti Claudio; Appelbaum Frederick R; Deeg Joachim; Hansen John A; Nash Richard A; Petersdorf Effie W; Storb Rainer; Ghetie Victor; Schindler John; Vitetta Ellen S
Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(8):552-60.
2004: Walter Roland B; Raden Brian W; Cronk Michelle R; Bernstein Irwin D; Appelbaum Frederick R; Banker Deborah E
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin.
Blood 2004;103(11):4276-84.
2004: Martin Paul J; McDonald George B; Sanders Jean E; Anasetti Claudio; Appelbaum Frederick R; Deeg H Joachim; Nash Richard A; Petersdorf Effie W; Hansen John A; Storb Rainer
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(5):320-7.
2004: Yusuf U; Frangoul H A; Gooley T A; Woolfrey A E; Carpenter P A; Andrews R G; Deeg H J; Appelbaum F R; Anasetti C; Storb R; Sanders J E
Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience.
Bone marrow transplantation 2004;33(8):805-14.
2004: Randolph Sophia S B; Gooley Theodore A; Warren Edus H; Appelbaum Frederick R; Riddell Stanley R
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.
Blood 2004;103(1):347-52.
2003: Stewart B; Verdugo M; Guthrie K A; Appelbaum F; Deeg H J
Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes.
British journal of haematology 2003;123(5):879-85.
2003: Benesch M; McDonald G B; Schubert M; Appelbaum F R; Deeg H J
Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study.
Bone marrow transplantation 2003;32(11):1071-5.
2003: Deeg H Joachim; Gooley Theodore A; Flowers Mary E D; Sale George E; Slattery John T; Anasetti Claudio; Chauncey Thomas R; Doney Kristine; Georges George E; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie W; Radich Jerald; Sanders Jean E; Sandmaier Brenda M; Warren E Houston; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Blood 2003;102(12):3912-8.
2003: Maloney David G; Molina Arthur J; Sahebi Firoozeh; Stockerl-Goldstein Keith E; Sandmaier Brenda M; Bensinger William; Storer Barry; Hegenbart Ute; Somlo George; Chauncey Thomas; Bruno Benedetto; Appelbaum Frederick R; Blume Karl G; Forman Stephen J; McSweeney Peter; Storb Rainer
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.
Blood 2003;102(9):3447-54.
2003: Gopal Ajay K; Gooley Theodore A; Maloney David G; Petersdorf Stephen H; Eary Janet F; Rajendran Joseph G; Bush Sharon A; Durack Lawrence D; Golden Jane; Martin Paul J; Matthews Dana C; Appelbaum Frederick R; Bernstein Irwin D; Press Oliver W
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.
Blood 2003;102(7):2351-7.
2003: Chen Chien-Shing; Boeckh M; Seidel K; Clark J G; Kansu E; Madtes D K; Wagner J L; Witherspoon R P; Anasetti C; Appelbaum F R; Bensinger W I; Deeg H J; Martin P J; Sanders J E; Storb R; Storek J; Wade J; Siadak M; Flowers M E D; Sullivan K M
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;32(5):515-22.
2003: Gutierrez-Delgado F; Holmberg L; Hooper H; Petersdorf S; Press O; Maziarz R; Maloney D; Chauncey T; Appelbaum F; Bensinger W
Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen.
Bone marrow transplantation 2003;32(3):279-85.
2003: Doney Kristine; Hägglund Hans; Leisenring Wendy; Chauncey Thomas; Appelbaum Frederick R; Storb Rainer
Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(7):472-81.
2003: Radich Jerald P; Gooley Ted; Bensinger William; Chauncey Thomas; Clift Reginald; Flowers Mary; Martin Paul; Slattery John; Sultan Debbie; Appelbaum Frederick R
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen.
Blood 2003;102(1):31-5.
2003: Li Henry Y; Appelbaum Frederick R; Willman Cheryl L; Zager Richard A; Banker Deborah E
Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses.
Blood 2003;101(9):3628-34.
2003: Stirewalt Derek L; Guthrie Katherine A; Beppu Lan; Bryant Eileen M; Doney Kris; Gooley Ted; Appelbaum Frederick R; Radich Jerald P
Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(3):206-12.
2003: Hsi Eric D; Kopecky Kenneth J; Appelbaum Frederick R; Boldt David; Frey Tom; Loftus Margaret; Hussein Mohamad A
Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia.
British journal of haematology 2003;120(6):1017-25.
2003: Appelbaum F R
New targets for therapy in acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(3):492-5.
2003: Stirewalt D L; Appelbaum F R; Willman C L; Zager R A; Banker D E
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression.
Leukemia research 2003;27(2):133-45.
2003: Feinstein Lyle C; Sandmaier Brenda M; Hegenbart Ute; McSweeney Peter A; Maloney David G; Gooley Theodore A; Maris Michael B; Chauncey Thomas R; Bruno Benedetto; Appelbaum Frederick R; Niederwieser Dietger W; Storb Rainer F
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.
British journal of haematology 2003;120(2):281-8.
2003: Appelbaum Frederick R
The current status of hematopoietic cell transplantation.
Annual review of medicine 2003;54():491-512.
2002: Anderson Jeanne E; Kopecky Kenneth J; Willman Cheryl L; Head David; O'Donnell Margaret R; Luthardt Frederick W; Norwood Thomas H; Chen I-Ming; Balcerzak Stanley P; Johnson David B; Appelbaum Frederick R
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.
Blood 2002;100(12):3869-76.
2002: Larson R A; Boogaerts M; Estey E; Karanes C; Stadtmauer E A; Sievers E L; Mineur P; Bennett J M; Berger M S; Eten C B; Munteanu M; Loken M R; Van Dongen J J M; Bernstein I D; Appelbaum F R;
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1627-36.
2002: List Alan F; Kopecky Kenneth J; Willman Cheryl L; Head David R; Slovak Marilyn L; Douer Dan; Dakhil Shaker R; Appelbaum Frederick R
Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase.
Blood 2002;100(5):1910-2.
2002: McCune J S; Gooley T; Gibbs J P; Sanders J E; Petersdorf E W; Appelbaum F R; Anasetti C; Risler L; Sultan D; Slattery J T
Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation.
Bone marrow transplantation 2002;30(3):167-73.
2002: Deeg H Joachim; Storer Barry; Slattery John T; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie; Radich Jerald P; Sanders Jean E; Shulman Howard M; Warren Edus H; Witherspoon Robert P; Bryant Eileen M; Chauncey Thomas R; Getzendaner Lisa; Storb Rainer; Appelbaum Frederick R
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.
Blood 2002;100(4):1201-7.
2002: Platzbecker Uwe; Gooley Ted; Anasetti Claudio; Appelbaum Frederick R; Clurman Bruce; Doney Kris; Chauncey Thomas; Flowers Mary E D; Myerson David; Radich Jerald P; Storb Rainer; Witherspoon Robert P; Deeg H Joachim
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation.
Leukemia & lymphoma 2002;43(7):1409-14.
2002: Flowers Mary E D; Parker Pablo M; Johnston Laura J; Matos Alice V B; Storer Barry; Bensinger William I; Storb Rainer; Appelbaum Frederick R; Forman Stephen J; Blume Karl G; Martin Paul J
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
Blood 2002;100(2):415-9.
2002: Koc Sibel; Leisenring Wendy; Flowers Mary E D; Anasetti Claudio; Deeg H Joachim; Nash Richard A; Sanders Jean E; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R; Martin Paul J
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
Blood 2002;100(1):48-51.
2002: Wolman Sandra R; Gundacker Holly; Appelbaum Frederick R; Slovak Marilyn L;
Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study.
Blood 2002;100(1):29-35.
2002: Doney K C; Chauncey T; Appelbaum F R;
Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia.
Bone marrow transplantation 2002;29(10):817-23.
2002: Pagel J M; Matthews D C; Appelbaum F R; Bernstein I D; Press O W
The use of radioimmunoconjugates in stem cell transplantation.
Bone marrow transplantation 2002;29(10):807-16.
2002: Gopal Ajay K; Rajendran Joseph G; Petersdorf Stephen H; Maloney David G; Eary Janet F; Wood Brent L; Gooley Theodore A; Bush Sharon A; Durack Lawrence D; Martin Paul J; Matthews Dana C; Appelbaum Frederick R; Bernstein Irwin D; Press Oliver W
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.
Blood 2002;99(9):3158-62.
2002: Appelbaum Frederick R
Hematopoietic cell transplantation as a form of immunotherapy.
International journal of hematology 2002;75(3):222-7.
2002: Carpenter Paul A; Appelbaum Frederick R; Corey Lawrence; Deeg H Joachim; Doney Kris; Gooley Theodore; Krueger James; Martin Paul; Pavlovic Sandra; Sanders Jean; Slattery John; Levitt Daniel; Storb Rainer; Woolfrey Ann; Anasetti Claudio
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease.
Blood 2002;99(8):2712-9.
2002: Woolfrey Ann E; Anasetti Claudio; Storer Barry; Doney Kristine; Milner Laurie A; Sievers Eric L; Carpenter Paul; Martin Paul; Petersdorf Effie; Appelbaum Frederick R; Hansen John A; Sanders Jean E
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.
Blood 2002;99(6):2002-8.
2002: Deeg H J; Gotlib J; Beckham C; Dugan K; Holmberg L; Schubert M; Appelbaum F; Greenberg P
Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(2):162-4.
2002: Appelbaum F R
Hematopoietic cell transplantation beyond first remission.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(2):157-9.
2002: Banker Deborah E; Cooper John J; Fennell Dean A; Willman Cheryl L; Appelbaum Frederick R; Cotter Finbarr E
PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism.
Leukemia research 2002;26(1):91-106.
2002: Furlong Terry; Leisenring Wendy; Storb Rainer; Anasetti Claudio; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Kiem Hans-Peter; Nash Richard A; Sanders Jean E; Witherspoon Robert; Thompson Dianne; Martin Paul J
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(4):206-12.
2001: Benito A I; Furlong T; Martin P J; Anasetti C; Appelbaum F R; Doney K; Nash R A; Papayannopoulou T; Storb R; Sullivan K M; Witherspoon R; Deeg H J
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.
Transplantation 2001;72(12):1924-9.
2001: Kansu E; Gooley T; Flowers M E; Anasetti C; Deeg H J; Nash R A; Sanders J E; Witherspoon R P; Appelbaum F R; Storb R; Martin P J
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial.
Blood 2001;98(13):3868-70.
2001: Storek J; Joseph A; Espino G; Dawson M A; Douek D C; Sullivan K M; Flowers M E; Martin P; Mathioudakis G; Nash R A; Storb R; Appelbaum F R; Maloney D G
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.
Blood 2001;98(13):3505-12.
2001: List A F; Kopecky K J; Willman C L; Head D R; Persons D L; Slovak M L; Dorr R; Karanes C; Hynes H E; Doroshow J H; Shurafa M; Appelbaum F R
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study.
Blood 2001;98(12):3212-20.
2001: Gutierrez-Delgado F; Maloney D G; Press O W; Golden J; Holmberg L A; Maziarz R T; Hooper H; Buckner C D; Appelbaum F R; Bensinger W I
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens.
Bone marrow transplantation 2001;28(5):455-61.
2001: Radich J P; Gooley T; Bryant E; Chauncey T; Clift R; Beppu L; Edmands S; Flowers M E; Kerkof K; Nelson R; Appelbaum F R
The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation.
Blood 2001;98(6):1701-7.
2001: Linenberger M L; Hong T; Flowers D; Sievers E L; Gooley T A; Bennett J M; Berger M S; Leopold L H; Appelbaum F R; Bernstein I D
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin.
Blood 2001;98(4):988-94.
2001: Anderson J E; Tefferi A; Craig F; Holmberg L; Chauncey T; Appelbaum F R; Guardiola P; Callander N; Freytes C; Gazitt Y; Razvillas B; Deeg H J
Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis.
Blood 2001;98(3):586-93.
2001: Appelbaum F R
Perspectives on the future of chronic myeloid leukemia treatment.
Seminars in hematology 2001;38(3 Suppl 8):35-42.
2001: Sievers E L; Larson R A; Stadtmauer E A; Estey E; Löwenberg B; Dombret H; Karanes C; Theobald M; Bennett J M; Sherman M L; Berger M S; Eten C B; Loken M R; van Dongen J J; Bernstein I D; Appelbaum F R;
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(13):3244-54.
2001: Stirewalt D L; Kopecky K J; Meshinchi S; Appelbaum F R; Slovak M L; Willman C L; Radich J P
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.
Blood 2001;97(11):3589-95.
2001: McSweeney P A; Niederwieser D; Shizuru J A; Sandmaier B M; Molina A J; Maloney D G; Chauncey T R; Gooley T A; Hegenbart U; Nash R A; Radich J; Wagner J L; Minor S; Appelbaum F R; Bensinger W I; Bryant E; Flowers M E; Georges G E; Grumet F C; Kiem H P; Torok-Storb B; Yu C; Blume K G; Storb R F
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Blood 2001;97(11):3390-400.
2001: Storek J; Dawson M A; Storer B; Stevens-Ayers T; Maloney D G; Marr K A; Witherspoon R P; Bensinger W; Flowers M E; Martin P; Storb R; Appelbaum F R; Boeckh M
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.
Blood 2001;97(11):3380-9.
2001: Al-Ghamdi H; Leisenring W; Bensinger W I; Nash R A; Storb R; Appelbaum F R; Martin P J
A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest.
British journal of haematology 2001;113(2):461-9.
2001: Appelbaum F R
Haematopoietic cell transplantation as immunotherapy.
Nature 2001;411(6835):385-9.
2001: Rowley S D; Donaldson G; Lilleby K; Bensinger W I; Appelbaum F R
Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation.
Blood 2001;97(9):2541-8.
2001: Appelbaum F R
Who should be transplanted for AML?
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(4):680-2.
2001: Witherspoon R P; Deeg H J; Storer B; Anasetti C; Storb R; Appelbaum F R
Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2134-41.
2001: Garrido S M; Appelbaum F R; Willman C L; Banker D E
Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).
Experimental hematology 2001;29(4):448-57.
2001: Gopal A K; Gooley T A; Golden J B; Maloney D G; Bensinger W I; Petersdorf S H; Appelbaum F R; Press O W
Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.
Bone marrow transplantation 2001;27(6):593-9.
2001: Petersdorf S H; Kopecky K J; Head D R; Boldt D H; Balcerzak S P; Wun T; Roy V; Veith R W; Appelbaum F R
Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(2):208-16.
2001: Jurado M; Deeg H; Gooley T; Anasetti C; Chauncey T; Flowers M; Myerson D; Storb R; Appelbaum F
Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia.
British journal of haematology 2001;112(2):392-6.
2001: Bensinger W I; Martin P J; Storer B; Clift R; Forman S J; Negrin R; Kashyap A; Flowers M E; Lilleby K; Chauncey T R; Storb R; Appelbaum F R
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
The New England journal of medicine 2001;344(3):175-81.
2001: Garrido S M; Cooper J J; Appelbaum F R; Willman C L; Kopecky K; Banker D E
Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis.
Leukemia research 2001;25(1):23-32.
2001: Appelbaum F R; Rowe J M; Radich J; Dick J E
Acute myeloid leukemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2001;():62-86.
2001: Anderson J E; Appelbaum F R; Schoch G; Barnett T; Chauncey T R; Flowers M E; Storb R
Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(3):163-70.
2001: Storb R; Blume K G; O'Donnell M R; Chauncey T; Forman S J; Deeg H J; Hu W W; Appelbaum F R; Doney K; Flowers M E; Sanders J; Leisenring W
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):39-44.
2000: Slovak M L; Kopecky K J; Cassileth P A; Harrington D H; Theil K S; Mohamed A; Paietta E; Willman C L; Head D R; Rowe J M; Forman S J; Appelbaum F R
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.
Blood 2000;96(13):4075-83.
2000: Koc S; Leisenring W; Flowers M E; Anasetti C; Deeg H J; Nash R A; Sanders J E; Witherspoon R P; Appelbaum F R; Storb R; Martin P J
Thalidomide for treatment of patients with chronic graft-versus-host disease.
Blood 2000;96(12):3995-6.
2000: Appelbaum F R; Baer M R; Carabasi M H; Coutre S E; Erba H P; Estey E; Glenn M J; Kraut E H; Maslak P; Millenson M; Miller C B; Saba H I; Stone R; Tallman M S;
NCCN Practice Guidelines for Acute Myelogenous Leukemia.
Oncology (Williston Park, N.Y.) 2000;14(11A):53-61.
2000: Furlong T; Storb R; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K; Witherspoon R; Nash R A
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
Bone marrow transplantation 2000;26(9):985-91.
2000: Press O W; Eary J F; Gooley T; Gopal A K; Liu S; Rajendran J G; Maloney D G; Petersdorf S; Bush S A; Durack L D; Martin P J; Fisher D R; Wood B; Borrow J W; Porter B; Smith J P; Matthews D C; Appelbaum F R; Bernstein I D
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.
Blood 2000;96(9):2934-42.
2000: Koc S; Hagglund H; Ireton R C; Perez-Simon J A; Collins S J; Appelbaum F R
Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2000;26(8):899-901.
2000: Sierra J; Storer B; Hansen J A; Martin P J; Petersdorf E W; Woolfrey A; Matthews D; Sanders J E; Storb R; Appelbaum F R; Anasetti C
Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience.
Bone marrow transplantation 2000;26(4):397-404.
2000: Deeg H J; Appelbaum F R
Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
Leukemia research 2000;24(8):653-63.
2000: Zang D Y; Deeg H J; Gooley T; Anderson J E; Anasetti C; Sanders J; Myerson D; Storb R; Appelbaum F
Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation.
British journal of haematology 2000;110(1):217-22.
2000: Gutierrez-Delgado F; Holmberg L A; Hooper H; Appelbaum F R; Livingston R B; Maziarz R T; Weiden P; Rivkin S; Montgomery P; Kawahara K; Bensinger W
High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer.
Bone marrow transplantation 2000;26(1):51-9.
2000: Chauncey T R; Rankin C; Anderson J E; Chen I; Kopecky K J; Godwin J E; Kalaycio M E; Moore D F; Shurafa M S; Petersdorf S H; Kraut E H; Leith C P; Head D R; Luthardt F W; Willman C L; Appelbaum F R
A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617.
Leukemia research 2000;24(7):567-74.
2000: Garrido S M; Bryant E; Appelbaum F R
Allogeneic stem cell transplantation for relapsed and refractory acute myeloid leukemia patients with 11q23 abnormalities.
Leukemia research 2000;24(6):481-6.
2000: Garrido S M; Willman C; Appelbaum F R; Banker D E
Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples.
Cytometry 2000;42(2):83-94.
2000: Rosen P J; Rankin C; Head D R; Boldt D H; Luthardt F W; Norwood T; Pugh R P; Karanes C; Appelbaum F R
A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia.
Leukemia research 2000;24(3):183-7.
2000: Appelbaum F R
Is there a best transplant conditioning regimen for acute myeloid leukemia?
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(3):497-501.
2000: Deeg H J; Shulman H M; Anderson J E; Bryant E M; Gooley T A; Slattery J T; Anasetti C; Fefer A; Storb R; Appelbaum F R
Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.
Blood 2000;95(4):1188-94.
2000: Cavallaro A M; Lilleby K; Majolino I; Storb R; Appelbaum F R; Rowley S D; Bensinger W I
Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
Bone marrow transplantation 2000;25(1):85-9.
2000: Flowers M E; Leisenring W; Beach K; Riddell S; Radich J P; Higano C S; Rowley S D; Chauncey T R; Sanders J E; Anasetti C; Storb R; Wade J; Appelbaum F R; Martin P
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3A):321-6.
2000: Radich J P; Gooley T; Sanders J E; Anasetti C; Chauncey T; Appelbaum F R
Second allogeneic transplantation after failure of first autologous transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3):272-9.
2000: Nash R A; Kurzrock R; DiPersio J; Vose J; Linker C; Maharaj D; Nademanee A P; Negrin R; Nimer S; Shulman H; Ashby M; Jones D; Appelbaum F R; Champlin R
A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(1):25-34.
1999: Clift R A; Radich J; Appelbaum F R; Martin P; Flowers M E; Deeg H J; Storb R; Thomas E D
Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants during chronic phase of chronic myeloid leukemia.
Blood 1999;94(11):3960-2.
1999: Holmberg L A; Boeckh M; Hooper H; Leisenring W; Rowley S; Heimfeld S; Press O; Maloney D G; McSweeney P; Corey L; Maziarz R T; Appelbaum F R; Bensinger W
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation.
Blood 1999;94(12):4029-35.
1999: Appelbaum F R
Molecular diagnosis and clinical decisions in adult acute leukemia.
Seminars in hematology 1999;36(4):401-10.
1999: Appelbaum F R
Antibody-targeted therapy for myeloid leukemia.
Seminars in hematology 1999;36(4 Suppl 6):2-8.
1999: Martin P J; Rowley S D; Anasetti C; Chauncey T R; Gooley T; Petersdorf E W; van Burik J A; Flowers M E; Storb R; Appelbaum F R; Hansen J A
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.
Blood 1999;94(7):2192-9.
1999: Karanes C; Kopecky K J; Head D R; Grever M R; Hynes H E; Kraut E H; Vial R H; Lichtin A; Nand S; Samlowski W E; Appelbaum F R
A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group Study.
Leukemia research 1999;23(9):787-94.
1999: Matthews D C; Appelbaum F R; Eary J F; Fisher D R; Durack L D; Hui T E; Martin P J; Mitchell D; Press O W; Storb R; Bernstein I D
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.
Blood 1999;94(4):1237-47.
1999: Leith C P; Kopecky K J; Chen I M; Eijdems L; Slovak M L; McConnell T S; Head D R; Weick J; Grever M R; Appelbaum F R; Willman C L
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
Blood 1999;94(3):1086-99.
1999: Stirewalt D L; Clurman B; Appelbaum F R; Willman C L; Radich J P
p73 mutations and expression in adult de novo acute myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(7):985-90.
1999: Appelbaum F R
Choosing the source of stem cells for allogeneic transplantation: no longer a peripheral issue.
Blood 1999;94(2):381-3.
1999: Gibbs J P; Gooley T; Corneau B; Murray G; Stewart P; Appelbaum F R; Slattery J T
The impact of obesity and disease on busulfan oral clearance in adults.
Blood 1999;93(12):4436-40.
1999: Sievers E L; Appelbaum F R; Spielberger R T; Forman S J; Flowers D; Smith F O; Shannon-Dorcy K; Berger M S; Bernstein I D
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate.
Blood 1999;93(11):3678-84.
1999: Matthews D C; Martin P J; Nourigat C; Appelbaum F R; Fisher D R; Bernstein I D
Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models.
Blood 1999;93(2):737-45.
1999: Storb R; Raff R F; Graham T; Appelbaum F R; Deeg H J; Schuening F G; Sale G; Seidel K
Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(3):155-61.
1998: Banker D E; Radich J; Becker A; Kerkof K; Norwood T; Willman C; Appelbaum F R
The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):3051-62.
1998: Cassileth P A; Harrington D P; Appelbaum F R; Lazarus H M; Rowe J M; Paietta E; Willman C; Hurd D D; Bennett J M; Blume K G; Head D R; Wiernik P H
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.
The New England journal of medicine 1998;339(23):1649-56.
1998: Woolfrey A E; Gooley T A; Sievers E L; Milner L A; Andrews R G; Walters M; Hoffmeister P; Hansen J A; Anasetti C; Bryant E; Appelbaum F R; Sanders J E
Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
Blood 1998;92(10):3546-56.
1998: Martin P J; Schoch G; Gooley T; Anasetti C; Deeg H J; Nash R; Sanders J; Storb R; Appelbaum F
Methods for assessment of graft-versus-host disease.
Blood 1998;92(9):3479-81.
1998: Holmberg L A; Demirer T; Rowley S; Buckner C D; Goodman G; Maziarz R; Klarnet J; Zuckerman N; Harrer G; McCloskey R; Gersh R; Goldberg R; Nichols W; Jacobs A; Weiden P; Montgomery P; Rivkin S; Appelbaum F R; Bensinger W I
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.
Bone marrow transplantation 1998;22(7):651-9.
1998: Liu S Y; Eary J F; Petersdorf S H; Martin P J; Maloney D G; Appelbaum F R; Matthews D C; Bush S A; Durack L D; Fisher D R; Gooley T A; Bernstein I D; Press O W
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3270-8.
1998: Appelbaum F R; Anderson J
Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12 Suppl 1():S25-9.
1998: Clift R A; Buckner C D; Appelbaum F R; Sullivan K M; Storb R; Thomas E D
Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia.
Blood 1998;92(4):1455-6.
1998: Morton A J; Gooley T; Hansen J A; Appelbaum F R; Bruemmer B; Bjerke J W; Clift R; Martin P J; Petersdorf E W; Sanders J E; Storb R; Sullivan K M; Woolfrey A; Anasetti C
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.
Blood 1998;92(2):394-401.
1998: Rowley S D; Loken M; Radich J; Kunkle L A; Mills B J; Gooley T; Holmberg L; McSweeney P; Beach K; MacLeod B; Appelbaum F; Bensinger W I
Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system.
Bone marrow transplantation 1998;21(12):1253-62.
1998: Sullivan K M; Anasetti C; Horowitz M; Rowlings P A; Petersdorf E W; Martin P J; Clift R A; Walters M C; Gooley T; Sierra J; Anderson J E; Bjerke J; Siadak M; Flowers M E; Nash R A; Sanders J E; Appelbaum F R; Storb R; Hansen J A
Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry.
Annals of the New York Academy of Sciences 1998;850():312-24.
1998: Appelbaum F R; Anderson J
Bone marrow transplantation for myelodysplasia in adults and children: when and who?
Leukemia research 1998;22 Suppl 1():S35-9.
1998: Godwin J E; Kopecky K J; Head D R; Willman C L; Leith C P; Hynes H E; Balcerzak S P; Appelbaum F R
A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).
Blood 1998;91(10):3607-15.
1998: Sandmaier B M; Storb R; Bennett K L; Appelbaum F R; Santos E B
Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model.
Blood 1998;91(9):3494-502.
1998: Hansen J A; Gooley T A; Martin P J; Appelbaum F; Chauncey T R; Clift R A; Petersdorf E W; Radich J; Sanders J E; Storb R F; Sullivan K M; Anasetti C
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.
The New England journal of medicine 1998;338(14):962-8.
1998: Banker D E; Groudine M; Willman C L; Norwood T; Appelbaum F R
Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.
Leukemia research 1998;22(3):221-39.
1998: Storb R; Raff R; Deeg H J; Graham T; Appelbaum F R; Schuening F G; Shulman H; Seidel K; Leisenring W
Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts.
International journal of radiation oncology, biology, physics 1998;40(4):961-6.
1998: Martin P; Nash R; Sanders J; Leisenring W; Anasetti C; Deeg H J; Storb R; Appelbaum F
Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation.
Bone marrow transplantation 1998;21(3):273-9.
1998: Sullivan K M; Kansu E; Storer B; Jocom J; Emerson G; Reagan T; Emerson V; Siadak M F; Davis C; Appelbaum F R; Buckner C D; Hansen J A; Shulman H M; Storb R; McDonald G B
Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(1):20-6.
1997: Chen C S; Seidel K; Armitage J O; Fay J W; Appelbaum F R; Horowitz M M; Shpall E J; Weiden P L; Antman K S; Champlin R E; Kersey J H; Sullivan K M
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(6):331-40.
1997: Storek J; Gooley T; Siadak M; Bensinger W I; Maloney D G; Chauncey T R; Flowers M; Sullivan K M; Witherspoon R P; Rowley S D; Hansen J A; Storb R; Appelbaum F R
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease.
Blood 1997;90(12):4705-9.
1997: Schiffman K; Buckner C D; Maziarz R; Maloney D G; Appelbaum F R; Press O; Gooley T; Holmberg L; Lilleby K; Clift R; Zuckerman N; Klarnet J; Weaver C; Chauncey T; Bensinger W I
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):261-6.
1997: Schuening F G; von Kalle C; Kiem H P; Appelbaum F R; Deeg H J; Pepe M; Gooley T; Graham T C; Hackman R C; Storb R
Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
Experimental hematology 1997;25(12):1240-5.
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K M; Witherspoon R; Pettinger M; Bensinger W; Buckner C D; Clift R; Flowers M E; Hansen J A; Pepe M; Chauncey T; Sanders J; Thomas E D
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(4):194-201.
1997: Sierra J; Radich J; Hansen J A; Martin P J; Petersdorf E W; Bjerke J; Bryant E; Nash R A; Sanders J E; Storb R; Sullivan K M; Appelbaum F R; Anasetti C
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Blood 1997;90(4):1410-4.
1997: Anderson J E; Appelbaum F R
Myelodysplasia and myeloproliferative disorders.
Current opinion in hematology 1997;4(4):261-7.
1997: Bensinger W I; Schiffman K S; Holmberg L; Appelbaum F R; Maziarz R; Montgomery P; Ellis E; Rivkin S; Weiden P; Lilleby K; Rowley S; Petersdorf S; Klarnet J P; Nichols W; Hertler A; McCroskey R; Weaver C H; Buckner C D
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.
Bone marrow transplantation 1997;19(12):1183-9.
1997: Sierra J; Storer B; Hansen J A; Bjerke J W; Martin P J; Petersdorf E W; Appelbaum F R; Bryant E; Chauncey T R; Sale G; Sanders J E; Storb R; Sullivan K M; Anasetti C
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.
Blood 1997;89(11):4226-35.
1997: Appelbaum F R
Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 4():S15-7.
1997: Deeg H J; Lin D; Leisenring W; Boeckh M; Anasetti C; Appelbaum F R; Chauncey T R; Doney K; Flowers M; Martin P; Nash R; Schoch G; Sullivan K M; Witherspoon R P; Storb R
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Blood 1997;89(10):3880-7.
1997: Leith C P; Kopecky K J; Godwin J; McConnell T; Slovak M L; Chen I M; Head D R; Appelbaum F R; Willman C L
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.
Blood 1997;89(9):3323-9.
1997: Radich J; Gehly G; Lee A; Avery R; Bryant E; Edmands S; Gooley T; Kessler P; Kirk J; Ladne P; Thomas E D; Appelbaum F R
Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation.
Blood 1997;89(7):2602-9.
1997: Anderson J E; Gooley T A; Schoch G; Anasetti C; Bensinger W I; Clift R A; Hansen J A; Sanders J E; Storb R; Appelbaum F R
Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy.
Blood 1997;89(7):2578-85.
1997: Slattery J T; Clift R A; Buckner C D; Radich J; Storer B; Bensinger W I; Soll E; Anasetti C; Bowden R; Bryant E; Chauncey T; Deeg H J; Doney K C; Flowers M; Gooley T; Hansen J A; Martin P J; McDonald G B; Nash R; Petersdorf E W; Sanders J E; Schoch G; Stewart P; Storb R; Sullivan K M; Thomas E D; Witherspoon R P; Appelbaum F R
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.
Blood 1997;89(8):3055-60.
1997: Robinson N; Benyunes M C; Thompson J A; York A; Petersdorf S; Press O; Lindgren C; Chauncey T; Buckner C D; Bensinger W I; Appelbaum F R; Fefer A
Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study.
Bone marrow transplantation 1997;19(5):435-42.
1997: Demirer T; Buckner C D; Storer B; Lilleby K; Rowley S; Clift R; Appelbaum F R; Storb R; Bensinger W I
Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):684-90.
1997: Appelbaum F R
Allogeneic hematopoietic stem cell transplantation for acute leukemia.
Seminars in oncology 1997;24(1):114-23.
1997: Doney K; Leisenring W; Storb R; Appelbaum F R
Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
Annals of internal medicine 1997;126(2):107-15.
1997: Banker D E; Groudine M; Norwood T; Appelbaum F R
Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia.
Blood 1997;89(1):243-55.
1997: Matthews D C; Appelbaum F R; Press O W; Eary J F; Bernstein I D
The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies.
Cancer treatment and research 1997;77():121-39.
1996: Tsai T; Davalath S; Rankin C; Radich J P; Head D; Appelbaum F R; Boldt D H
Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1996;10(12):1901-10.
1996: Bensinger W I; Buckner C D; Shannon-Dorcy K; Rowley S; Appelbaum F R; Benyunes M; Clift R; Martin P; Demirer T; Storb R; Lee M; Schiller G
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Blood 1996;88(11):4132-8.
1996: Corcoran M C; Press O W; Matthews D C; Appelbaum F R; Bernstein I D
The role of radioimmunotherapy in bone marrow transplantation.
Current opinion in hematology 1996;3(6):438-45.
1996: Huss R; Deeg H J; Gooley T; Bryant E; Leisenring W; Clift R; Buckner C D; Martin P; Storb R; Appelbaum F R
Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
Bone marrow transplantation 1996;18(4):767-76.
1996: Weick J K; Kopecky K J; Appelbaum F R; Head D R; Kingsbury L L; Balcerzak S P; Bickers J N; Hynes H E; Welborn J L; Simon S R; Grever M
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study.
Blood 1996;88(8):2841-51.
1996: Bensinger W I; Clift R; Martin P; Appelbaum F R; Demirer T; Gooley T; Lilleby K; Rowley S; Sanders J; Storb R; Buckner C D
Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation.
Blood 1996;88(7):2794-800.
1996: Bensinger W I; Buckner C D; Anasetti C; Clift R; Storb R; Barnett T; Chauncey T; Shulman H; Appelbaum F R
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome.
Blood 1996;88(7):2787-93.
1996: Bensinger W I; Demirer T; Buckner C D; Appelbaum F R; Storb R; Lilleby K; Weiden P; Bluming A Z; Fefer A
Syngeneic marrow transplantation in patients with multiple myeloma.
Bone marrow transplantation 1996;18(3):527-31.
1996: McSweeney P A; Rouleau K A; Storb R; Bolles L; Wallace P M; Beauchamp M; Krizanac-Bengez L; Moore P; Sale G; Sandmaier B; de Revel T; Appelbaum F R; Nash R A
Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein.
Blood 1996;88(6):1992-2003.
1996: Kiem H P; Leisenring W; Raff R; Deeg H J; Schuening F G; Appelbaum F R; Storb R
Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiation.
Blood 1996;88(5):1896-7.
1996: Martin P J; Nelson B J; Appelbaum F R; Anasetti C; Deeg H J; Hansen J A; McDonald G B; Nash R A; Sullivan K M; Witherspoon R P; Scannon P J; Friedmann N; Storb R
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.
Blood 1996;88(3):824-30.
1996: Brunvand M W; Bensinger W I; Soll E; Weaver C H; Rowley S D; Appelbaum F R; Lilleby K; Clift R A; Gooley T A; Press O W; Fefer A; Storb R; Sanders J E; Martin P L; Chauncey T; Maziarz R T; Zuckerman N; Montgomery P; Dorn R; Weiden P L; Demirer T; Holmberg L A; Schiffman K; McSweeney P A; Buckner C D
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
Bone marrow transplantation 1996;18(1):131-41.
1996: Schiffman K S; Bensinger W I; Appelbaum F R; Rowley S; Lilleby K; Clift R A; Weaver C H; Demirer T; Sanders J E; Petersdorf S; Gooley T; Weiden P; Zuckerman N; Montgomery P; Maziarz R; Klarnet J P; Rivkin S; Trueblood K; Storb R; Holmberg L; Buckner C D
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.
Bone marrow transplantation 1996;17(6):943-50.
1996: Demirer T; Buckner C D; Gooley T; Appelbaum F R; Rowley S; Chauncey T; Lilleby K; Storb R; Bensinger W I
Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
Bone marrow transplantation 1996;17(6):937-41.
1996: Kiem H P; McDonald G B; Myerson D; Spurgeon C L; Deeg H J; Sanders J E; Doney K; Appelbaum F R; Sullivan K M; Witherspoon R P; Storb R
Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):93-9.
1996: Walters M C; Patience M; Leisenring W; Eckman J R; Buchanan G R; Rogers Z R; Olivieri N E; Vichinsky E; Davies S C; Mentzer W C; Powars D; Scott J P; Bernaudin F; Ohene-Frempong K; Darbyshire P J; Wayne A; Roberts I A; Dinndorf P; Brandalise S; Sanders J E; Matthews D C; Appelbaum F R; Storb R; Sullivan K M
Barriers to bone marrow transplantation for sickle cell anemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):100-4.
1996: Demirer T; Buckner C D; Appelbaum F R; Clift R; Storb R; Myerson D; Lilleby K; Rowley S; Bensinger W I
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer.
Bone marrow transplantation 1996;17(5):769-74.
1996: Slattery J T; Kalhorn T F; McDonald G B; Lambert K; Buckner C D; Bensinger W I; Anasetti C; Appelbaum F R
Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1484-94.
1996: Bensinger W I; Rowley S D; Demirer T; Lilleby K; Schiffman K; Clift R A; Appelbaum F R; Fefer A; Barnett T; Storb R; Chauncey T; Maziarz R T; Klarnet J; McSweeney P; Holmberg L; Maloney D G; Weaver C H; Buckner C D
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1447-56.
1996: Press O W; Shan D; Howell-Clark J; Eary J; Appelbaum F R; Matthews D; King D J; Haines A M; Hamann P; Hinman L; Shochat D; Bernstein I D
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
Cancer research 1996;56(9):2123-9.
1996: Demirer T; Buckner C D; Appelbaum F R; Bensinger W I; Sanders J; Lambert K; Clift R; Fefer A; Storb R; Slattery J T
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Bone marrow transplantation 1996;17(4):491-5.
1996: Sanders J E; Hawley J; Levy W; Gooley T; Buckner C D; Deeg H J; Doney K; Storb R; Sullivan K; Witherspoon R; Appelbaum F R
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.
Blood 1996;87(7):3045-52.
1996: Anderson J E; Anasetti C; Appelbaum F R; Schoch G; Gooley T A; Hansen J A; Buckner C D; Sanders J E; Sullivan K M; Storb R
Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia.
British journal of haematology 1996;93(1):59-67.
1996: Bensinger W I; Buckner C D; Rowley S; Storb R; Appelbaum F R
Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells.
Bone marrow transplantation 1996;17 Suppl 2():S19-21.
1996: Demirer T; Buckner C D; Appelbaum F R; Lambert K; Bensinger W I; Clift R; Storb R; Slattery J T
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Bone marrow transplantation 1996;17(3):341-6.
1996: Sullivan K M; Storek J; Kopecky K J; Jocom J; Longton G; Flowers M; Siadak M; Nims J; Witherspoon R P; Anasetti C; Appelbaum F R; Bowden R A; Buckner C D; Crawford S W; Deeg H J; Hansen J A; McDonald G B; Sanders J E; Storb R
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(1):44-53.
1996: Robinson N; Sanders J E; Benyunes M C; Beach K; Lindgren C; Thompson J A; Appelbaum F R; Fefer A
Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia.
Blood 1996;87(4):1249-54.
1996: Bean M A; Graham T; Appelbaum F R; Deeg H J; Schuening F; Sale G E; Leisenring W; Pepe M; Storb R
Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts. Tolerance versus abrogation of sensitization to non-DLA antigens.
Transplantation 1996;61(2):334-5.
1996: Anderson J E; Appelbaum F R; Schoch G; Gooley T; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Chauncey T; Clift R A
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):220-6.
1996: Anderson J E; Appelbaum F R; Schoch G; Gooley T; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Chauncey T R; Clift R A; Doney K; Flowers M; Hansen J A; Martin P J; Matthews D C; Sanders J E; Shulman H; Sullivan K M; Witherspoon R P; Storb R
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Blood 1996;87(1):51-8.
1996: Nash R A; Gooley T; Davis C; Appelbaum F R
The problem of thrombocytopenia after hematopoietic stem cell transplantation.
Stem cells (Dayton, Ohio) 1996;14 Suppl 1():261-73.
1995: Bensinger W; Appelbaum F; Rowley S; Storb R; Sanders J; Lilleby K; Gooley T; Demirer T; Schiffman K; Weaver C
Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(10):2547-55.
1995: Balduzzi A; Gooley T; Anasetti C; Sanders J E; Martin P J; Petersdorf E W; Appelbaum F R; Buckner C D; Matthews D; Storb R; Sullivan K M; Hansen J A
Unrelated donor marrow transplantation in children.
Blood 1995;86(8):3247-56.
1995: Kalhs P; Schwarzinger I; Anderson G; Mori M; Clift R A; Storb R; Buckner C D; Appelbaum F R; Hansen J A; Sullivan K M
A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia.
Blood 1995;86(5):2028-32.
1995: Nash R A; Burstein S A; Storb R; Yang W; Abrams K; Appelbaum F R; Boone T; Deeg H J; Durack L D; Schuening F G
Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets.
Blood 1995;86(5):1765-75.
1995: Meyskens F L; Kopecky K J; Appelbaum F R; Balcerzak S P; Samlowski W; Hynes H
Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial.
Leukemia research 1995;19(9):605-12.
1995: Leith C P; Chen I M; Kopecky K J; Appelbaum F R; Head D R; Godwin J E; Weick J K; Willman C L
Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases.
Blood 1995;86(6):2329-42.
1995: Appelbaum F R; Clift R; Radich J; Anasetti C; Buckner C D
Bone marrow transplantation for chronic myelogenous leukemia.
Seminars in oncology 1995;22(4):405-11.
1995: Press O W; Eary J F; Appelbaum F R; Martin P J; Nelp W B; Glenn S; Fisher D R; Porter B; Matthews D C; Gooley T
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.
Lancet 1995;346(8971):336-40.
1995: Demirer T; Petersen F B; Appelbaum F R; Barnett T A; Sanders J; Deeg H J; Storb R; Doney K; Bensinger W I; Shannon-Dorcy K
Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.
International journal of radiation oncology, biology, physics 1995;32(4):1103-9.
1995: Slattery J T; Sanders J E; Buckner C D; Schaffer R L; Lambert K W; Langer F P; Anasetti C; Bensinger W I; Fisher L D; Appelbaum F R
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics.
Bone marrow transplantation 1995;16(1):31-42.
1995: Appelbaum F R
Allogeneic marrow transplantation and the use of hematopoietic growth factors.
Stem cells (Dayton, Ohio) 1995;13(4):344-50.
1995: Demirer T; Rowley S; Buckner C D; Appelbaum F R; Lilleby K; Storb R; Schiffman K; Bensinger W I
Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1714-9.
1995: Demirer T; Buckner C D; Appelbaum F R; Petersen F B; Rowley S; Weaver C H; Lilleby K; Sanders J; Chauncey T; Storb R
Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
Bone marrow transplantation 1995;15(6):915-22.
1995: Demirer T; Gooley T; Buckner C D; Petersen F B; Lilleby K; Rowley S; Sanders J; Storb R; Appelbaum F R; Bensinger W I
Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
Bone marrow transplantation 1995;15(6):907-13.
1995: Nash R A; Etzioni R; Storb R; Furlong T; Gooley T; Anasetti C; Appelbaum F R; Doney K; Martin P; Slattery J
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study.
Blood 1995;85(12):3746-53.
1995: Nash R A; Seidel K; Storb R; Slichter S; Schuening F G; Appelbaum F R; Becker A B; Bolles L; Deeg H J; Graham T
Effects of rhIL-11 on normal dogs and after sublethal radiation.
Experimental hematology 1995;23(5):389-96.
1995: Deeg H J; Seidel K; Bruemmer B; Pepe M S; Appelbaum F R
Impact of patient weight on non-relapse mortality after marrow transplantation.
Bone marrow transplantation 1995;15(3):461-8.
1995: Bensinger W I; Weaver C H; Appelbaum F R; Rowley S; Demirer T; Sanders J; Storb R; Buckner C D
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.
Blood 1995;85(6):1655-8.
1995: Matthews D C; Appelbaum F R; Eary J F; Fisher D R; Durack L D; Bush S A; Hui T E; Martin P J; Mitchell D; Press O W
Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.
Blood 1995;85(4):1122-31.
1995: Langenmayer I; Weaver C; Buckner C D; Lilleby K; Appelbaum F R; Longin K; Rowley S; Storb R; Singer J; Bensinger W I
Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both.
Bone marrow transplantation 1995;15(2):241-6.
1995: Lynch M H; Petersen F B; Appelbaum F R; Bensinger W I; Clift R A; Storb R; Sanders J E; Hansen J A; Buckner C D
Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.
Bone marrow transplantation 1995;15(1):59-64.
1995: Andrews R G; Briddell R A; Knitter G H; Rowley S D; Appelbaum F R; McNiece I K
Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates.
Blood 1995;85(1):15-20.
1995: Press O W; Eary J F; Appelbaum F R; Bernstein I D
Myeloablative radiolabeled antibody therapy with autologous bone marrow transplantation for relapsed B cell lymphomas.
Cancer treatment and research 1995;76():281-97.
1994: Weaver C H; Petersen F B; Appelbaum F R; Bensinger W I; Press O; Martin P; Sandmaier B; Deeg H J; Hansen J A; Brunvand M
High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2559-66.
1994: Boldt D H; Kopecky K J; Head D; Gehly G; Radich J P; Appelbaum F R
Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(12):2118-26.
1994: Weaver C H; Clift R A; Deeg H J; Storb R; Appelbaum F R; Bensinger W; Doney K; Hansen J A; Martin P O; Sanders J
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.
Bone marrow transplantation 1994;14(6):885-93.
1994: Weaver C H; Bensinger W I; Appelbaum F R; Lilleby K; Sandmaier B; Brunvand M; Rowley S; Petersdorf S; Rivkin S; Gooley T
Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies.
Bone marrow transplantation 1994;14(5):813-9.
1994: Storb R; Raff R F; Appelbaum F R; Deeg H J; Graham T C; Schuening F G; Shulman H; Yu C; Bryant E; Burnett R
DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors.
Blood 1994;84(10):3558-66.
1994: Radich J P; Kopecky K J; Boldt D H; Head D; Slovak M L; Babu R; Kirk J; Lee A; Kessler P; Appelbaum F
Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(10):1688-95.
1994: Nemunaitis J; Ross M; Meisenberg B; O'Reilly R; Lilleby K; Buckner C D; Appelbaum F R; Buhles W; Singer J; Peters W P
Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure.
Bone marrow transplantation 1994;14(4):583-8.
1994: Anasetti C; Hansen J A; Waldmann T A; Appelbaum F R; Davis J; Deeg H J; Doney K; Martin P J; Nash R; Storb R
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor.
Blood 1994;84(4):1320-7.
1994: Storb R; Etzioni R; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W; Bryant E; Clift R; Deeg H J; Doney K
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
Blood 1994;84(3):941-9.
1994: Bensinger W I; Longin K; Appelbaum F; Rowley S; Weaver C; Lilleby K; Gooley T; Lynch M; Higano T; Klarnet J
Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation.
British journal of haematology 1994;87(4):825-31.
1994: Andrews R G; Briddell R A; Knitter G H; Opie T; Bronsden M; Myerson D; Appelbaum F R; McNiece I K
In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells.
Blood 1994;84(3):800-10.
1994: Demirer T; Buckner C D; Lilleby K; Weaver C; Longin K; Appelbaum F R; Bensinger W I
Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease.
Cancer 1994;74(2):715-21.
1994: Eary J F; Pollard K R; Durack L D; Bice A N; Lewellen T K; Matthews D; Press O W; Nelp W B; Appelbaum F R; Bernstein I
Post therapy imaging in high dose I-131 radioimmunotherapy patients.
Medical physics 1994;21(7):1157-62.
1994: Scott A A; Head D R; Kopecky K J; Appelbaum F R; Theil K S; Grever M R; Chen I M; Whittaker M H; Griffith B B; Licht J D
HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Blood 1994;84(1):244-55.
1994: Nemunaitis J; Appelbaum F R; Lilleby K; Buhles W C; Rosenfeld C; Zeigler Z R; Shadduck R K; Singer J W; Meyer W; Buckner C D
Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia.
Blood 1994;83(12):3473-9.
1994: Storb R; Raff R F; Appelbaum F R; Deeg H J; Graham T C; Schuening F G; Sale G; Bryant E; Seidel K
Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts.
Blood 1994;83(11):3384-9.
1994: de Revel T; Appelbaum F R; Storb R; Schuening F; Nash R; Deeg J; McNiece I; Andrews R; Graham T
Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs.
Blood 1994;83(12):3795-9.
1994: Anderson J E; Appelbaum F R
Hematopoietic effects and clinical uses of granulocyte-macrophage colony-stimulating factor and PIXY321.
Current opinion in hematology 1994;1(3):203-9.
1994: Busca A; Anasetti C; Anderson G; Appelbaum F R; Buckner C D; Doney K; Martin P J; Petersdorf E; Sanders J E; Hansen J A
Unrelated donor or autologous marrow transplantation for treatment of acute leukemia.
Blood 1994;83(10):3077-84.
1994: Nash R A; Schuening F G; Seidel K; Appelbaum F R; Boone T; Deeg H J; Graham T C; Hackman R; Sullivan-Pepe M; Storb R
Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.
Blood 1994;83(7):1963-70.
1994: Deeg H J; Beckham C; Huss R; Myerson D; Greinix H; Appelbaum F R; Graham T; Schuening F; Storb R
Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand.
Blood 1994;83(8):2352-9.
1994: Schwarzinger I; Raff R F; Flowers M; Niederwieser D; Graham T; Shulman H; Appelbaum F R; Schuening F; Storb R
Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
Bone marrow transplantation 1994;13(3):303-9.
1994: Kiem H P; Darovsky B; von Kalle C; Goehle S; Stewart D; Graham T; Hackman R; Appelbaum F R; Deeg H J; Miller A D
Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells.
Blood 1994;83(6):1467-73.
1994: Bean M A; Graham T; Appelbaum F R; Deeg H J; Schuening F; Sale G E; Storb R
Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts.
Transplantation 1994;57(3):423-6.
1994: Bearman S I; Mori M; Beatty P G; Meyer W G; Buckner C D; Petersen F B; Sanders J E; Anasetti C; Martin P; Appelbaum F R
Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors.
Bone marrow transplantation 1994;13(1):31-5.
1994: Schuening F G; Nemunaitis J; Appelbaum F R; Storb R
Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials.
Bone marrow transplantation 1994;14 Suppl 4():S74-7.
1993: Anderson J E; Litzow M R; Appelbaum F R; Schoch G; Fisher L D; Buckner C D; Petersen F B; Crawford S W; Press O W; Sanders J E
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(12):2342-50.
1993: Appelbaum F R
The use of colony stimulating factors in marrow transplantation.
Cancer 1993;72(11 Suppl):3387-92.
1993: Nemunaitis J; Appelbaum F R; Singer J W; Lilleby K; Wolff S; Greer J P; Bierman P; Resta D; Campion M; Levitt D
Phase I trial with recombinant human interleukin-3 in patients with lymphoma undergoing autologous bone marrow transplantation.
Blood 1993;82(11):3273-8.
1993: Collins C; Eary J F; Donaldson G; Vernon C; Bush N E; Petersdorf S; Livingston R B; Gordon E E; Chapman C R; Appelbaum F R
Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(11):1839-44.
1993: Clift R A; Bianco J A; Appelbaum F R; Buckner C D; Singer J W; Bakke L; Bensinger W I; Bowden R A; McDonald G B; Schubert M
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.
Blood 1993;82(7):2025-30.
1993: Doney K; Buckner C D; Fisher L; Petersen F B; Sanders J; Appelbaum F R; Anasetti C; Badger C; Bensinger W; Deeg H J
Autologous bone marrow transplantation for acute lymphoblastic leukemia.
Bone marrow transplantation 1993;12(4):315-21.
1993: Storb R; Raff R F; Appelbaum F R; Deeg H J; Fitzsimmons W; Graham T C; Pepe M; Pettinger M; Sale G; van der Jagt R
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors.
Transplantation 1993;56(4):800-7.
1993: Press O W; Eary J F; Appelbaum F R; Martin P J; Badger C C; Nelp W B; Glenn S; Butchko G; Fisher D; Porter B
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.
The New England journal of medicine 1993;329(17):1219-24.
1993: Weaver C H; Buckner C D; Longin K; Appelbaum F R; Rowley S; Lilleby K; Miser J; Storb R; Hansen J A; Bensinger W
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor.
Blood 1993;82(7):1981-4.
1993: Nemunaitis J; Shannon-Dorcy K; Appelbaum F R; Meyers J; Owens A; Day R; Ando D; O'Neill C; Buckner D; Singer J
Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor.
Blood 1993;82(5):1422-7.
1993: Doney K; Storb R; Appelbaum F R; Buckner C D; Sanders J; Singer J; Hansen J A
Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia.
British journal of haematology 1993;85(1):182-4.
1993: Appelbaum F R
The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation.
Seminars in oncology 1993;20(4 Suppl 4):3-10; quiz 11.
1993: Anderson J E; Appelbaum F R; Fisher L D; Schoch G; Shulman H; Anasetti C; Bensinger W I; Bryant E; Buckner C D; Doney K
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome.
Blood 1993;82(2):677-81.
1993: Appelbaum F R
Indications for bone marrow transplantation (BMT) in the treatment of acute myeloid leukemia (AML).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(7):1081.
1993: Petersen F B; Lynch M H; Clift R A; Appelbaum F R; Sanders J E; Bensinger W I; Benyunes M C; Doney K; Fefer A; Martin P
Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1353-60.
1993: Weaver C H; Appelbaum F R; Petersen F B; Clift R; Singer J; Press O; Bensinger W; Bianco J; Martin P; Anasetti C
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1329-35.
1993: Eary J F; Collins C; Stabin M; Vernon C; Petersdorf S; Baker M; Hartnett S; Ferency S; Addison S J; Appelbaum F
Samarium-153-EDTMP biodistribution and dosimetry estimation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(7):1031-6.
1993: Raff R F; Severns E M; Storb R; Graham T C; Sale G; Schuening F G; Appelbaum F R
Studies of the use of L-leucyl-L-leucine methyl ester in canine allogeneic marrow transplantation.
Transplantation 1993;55(6):1244-9.
1993: Bensinger W; Singer J; Appelbaum F; Lilleby K; Longin K; Rowley S; Clarke E; Clift R; Hansen J; Shields T
Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor.
Blood 1993;81(11):3158-63.
1993: Storb R; Raff R F; Graham T; Appelbaum F R; Deeg H J; Schuening F G; Shulman H; Pepe M
Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model.
International journal of radiation oncology, biology, physics 1993;26(2):275-83.
1993: Bensinger W I; Price T H; Dale D C; Appelbaum F R; Clift R; Lilleby K; Williams B; Storb R; Thomas E D; Buckner C D
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.
Blood 1993;81(7):1883-8.
1993: Schiffman K; Clift R; Appelbaum F R; Sanders J; Bensinger W; Petersen F B; Rowley S; Hill R; Martin P; Storb R
Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia.
Bone marrow transplantation 1993;11(3):227-32.
1993: Pene R; Appelbaum F R; Fisher L; Lilleby K; Nemunaitis J; Storb R; Buckner C D
Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation.
Bone marrow transplantation 1993;11(3):219-22.
1993: Raff R F; Storb R; Graham T; Deeg H J; Pepe M; Schaffer R; Sale G E; Schuening F; Appelbaum F R
What role for 15-deoxyspergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease?
Transplantation 1993;55(3):684-8.
1993: Nemunaitis J; Anasetti C; Buckner C D; Appelbaum F R; Shannon-Dorcy K; Hansen J; Singer J W
Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation.
Blood 1993;81(3):865.
1993: Schuening F G; Appelbaum F R; Deeg H J; Sullivan-Pepe M; Graham T C; Hackman R; Zsebo K M; Storb R
Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.
Blood 1993;81(1):20-6.
1993: Press O W; Eary J; Badger C C; Appelbaum F R; Wiseman G; Matthews D; Martin P J; Bernstein I D
High-dose radioimmunotherapy of lymphomas.
Cancer treatment and research 1993;68():13-22.
1992: Andrews R G; Bensinger W I; Knitter G H; Bartelmez S H; Longin K; Bernstein I D; Appelbaum F R; Zsebo K M
The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons.
Blood 1992;80(11):2715-20.
1992: Raff R F; Storb R; Graham T; Sale G; Shulman H; Pepe M; Deeg H J; Schuening F; Appelbaum F R; Fidler J M
Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts.
Transplantation 1992;54(5):947-8.
1992: Anasetti C; Martin P J; Storb R; Appelbaum F R; Beatty P G; Davis J; Doney K; Hill H F; Stewart P; Sullivan K M
Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody.
Transplantation 1992;54(5):844-51.
1992: Appelbaum F R; Matthews D C; Eary J F; Badger C C; Kellogg M; Press O W; Martin P J; Fisher D R; Nelp W B; Thomas E D
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia.
Transplantation 1992;54(5):829-33.
1992: Raff R F; Storb R; Graham T; Fidler J M; Sale G E; Johnston B; Deeg H J; Pepe M; Schuening F; Appelbaum F R
Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone.
Transplantation 1992;54(5):813-20.
1992: Clift R A; Buckner C D; Appelbaum F R; Schoch G; Petersen F B; Bensinger W I; Sanders J; Sullivan K M; Storb R; Singer J
Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1723-9.
1992: Nash R A; Pepe M S; Storb R; Longton G; Pettinger M; Anasetti C; Appelbaum F R; Bowden R A; Deeg H J; Doney K
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Blood 1992;80(7):1838-45.
1992: Appelbaum F R; Brown P A; Sandmaier B M; Storb R; Fisher D R; Shulman H M; Graham T C; Schuening F G; Deeg H J; Bianco J A
Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP.
Blood 1992;80(6):1608-13.
1992: Bensinger W I; Buckner C D; Clift R A; Petersen F B; Bianco J A; Singer J W; Appelbaum F R; Dalton W; Beatty P; Fefer A
Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(9):1492-7.
1992: Andrews R G; Bartelmez S H; Knitter G H; Myerson D; Bernstein I D; Appelbaum F R; Zsebo K M
A c-kit ligand, recombinant human stem cell factor, mediates reversible expansion of multiple CD34+ colony-forming cell types in blood and marrow of baboons.
Blood 1992;80(4):920-7.
1992: Petersen F B; Buckner C D; Appelbaum F R; Sanders J E; Bensinger W I; Storb R; Deeg H J; Witherspoon R P; Sullivan K M; Clift R A
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
Bone marrow transplantation 1992;10(1):83-8.
1992: Doney K; Pepe M; Storb R; Bryant E; Anasetti C; Appelbaum F R; Buckner C D; Sanders J; Singer J; Sullivan K
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone.
Blood 1992;79(10):2566-71.
1992: Matthews D C; Badger C C; Fisher D R; Hui T E; Nourigat C; Appelbaum F R; Martin P J; Bernstein I D
Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody.
Cancer research 1992;52(5):1228-34.
1992: Flowers M E; Doney K C; Storb R; Deeg H J; Sanders J E; Sullivan K M; Bryant E; Witherspoon R P; Appelbaum F R; Buckner C D
Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience.
Bone marrow transplantation 1992;9(3):167-73.
1992: Stockschlaeder M; Storb R; Pepe M; Longton G; McDonald G; Anasetti C; Appelbaum F; Doney K; Martin P; Sullivan K
A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
British journal of haematology 1992;80(1):49-54.
1992: van der Jagt R H; Badger C C; Appelbaum F R; Press O W; Matthews D C; Eary J F; Krohn K A; Bernstein I D
Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model.
Cancer research 1992;52(1):89-94.
1992: Petersen F B; Deeg H J; Buckner C D; Appelbaum F R; Storb R; Clift R A; Sanders J E; Bensinger W I; Witherspoon R P; Sullivan K M
Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial.
International journal of radiation oncology, biology, physics 1992;23(5):1027-32.
1992: Buckner C D; Doney K; Sanders J; Petersen F; Appelbaum F
Marrow transplantation for patients with acute lymphoblastic leukemia: the Seattle experience.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 2():193-5.
1992: Clift R; Buckner C D; Bianco J; Petersen F; Appelbaum F
Marrow transplantation in patients with acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 2():104-9.
1992: Appelbaum F R; Badger C C; Bernstein I D; Buckner C D; Deeg H J; Eary J F; Matthews D C; Press O W; Storb R; Thomas E D
Is there a better way to deliver total body irradiation?
Bone marrow transplantation 1992;10 Suppl 1():77-81.
1992: Storb R; Longton G; Anasetti C; Appelbaum F R; Beatty P; Bensinger W; Crawford S; Deeg H J; Doney K; Fefer A
Changing trends in marrow transplantation for aplastic anemia.
Bone marrow transplantation 1992;10 Suppl 1():45-52.
1992: Sullivan K M; Mori M; Sanders J; Siadak M; Witherspoon R P; Anasetti C; Appelbaum F R; Bensinger W; Bowden R; Buckner C D
Late complications of allogeneic and autologous marrow transplantation.
Bone marrow transplantation 1992;10 Suppl 1():127-34.
1991: Bean M A; Storb R; Graham T; Raff R; Sale G E; Schuening F; Appelbaum F R
Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood.
Transplantation 1991;52(6):956-60.
1991: Schuening F G; Kawahara K; Miller A D; To R; Goehle S; Stewart D; Mullally K; Fisher L; Graham T C; Appelbaum F R
Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogs.
Blood 1991;78(10):2568-76.
1991: Badger C C; Davis J; Nourigat C; Wu Z M; Hui T E; Fisher D R; Shulman H; Appelbaum F R; Eary J F; Krohn K A
Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I.
Cancer research 1991;51(21):5921-8.
1991: Appelbaum F R
Radiolabeled monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
Hematology/oncology clinics of North America 1991;5(5):1013-25.
1991: Greinix H T; Ladiges W C; Graham T C; Maslan S; Raff R F; Sandmaier B M; Appelbaum F R; Schuening F G; Deeg H J; Storb R
Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody.
Blood 1991;78(8):2131-8.
1991: Andrews R G; Knitter G H; Bartelmez S H; Langley K E; Farrar D; Hendren R W; Appelbaum F R; Bernstein I D; Zsebo K M
Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates.
Blood 1991;78(8):1975-80.
1991: Matthews D C; Appelbaum F R; Eary J F; Hui T E; Fisher D R; Martin P J; Durack L D; Nelp W B; Press O W; Badger C C
Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque.
Blood 1991;78(7):1864-74.
1991: Van der Jagt R H; Appelbaum F R; Petersen F B; Bigelow C L; Fisher L D; Schoch G H; Buckner C D; Sanders J E; Storb R; Sullivan K M
Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.
Bone marrow transplantation 1991;8(3):211-5.
1991: Bianco J A; Appelbaum F R; Nemunaitis J; Almgren J; Andrews F; Kettner P; Shields A; Singer J W
Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation.
Blood 1991;78(5):1205-11.
1991: Nash R A; Schuening F; Appelbaum F; Hammond W P; Boone T; Morris C F; Slichter S J; Storb R
Molecular cloning and in vivo evaluation of canine granulocyte-macrophage colony-stimulating factor.
Blood 1991;78(4):930-7.
1991: Sullivan K M; Agura E; Anasetti C; Appelbaum F; Badger C; Bearman S; Erickson K; Flowers M; Hansen J; Loughran T
Chronic graft-versus-host disease and other late complications of bone marrow transplantation.
Seminars in hematology 1991;28(3):250-9.
1991: Storb R; Anasetti C; Appelbaum F; Bensinger W; Buckner C D; Clift R; Deeg H J; Doney K; Hansen J; Loughran T
Marrow transplantation for severe aplastic anemia and thalassemia major.
Seminars in hematology 1991;28(3):235-9.
1991: Buckner C D; Clift R A; Appelbaum F R; Storb R; Fefer A; Petersen F B; Sanders J E; Sullivan K; Thomas E D; Hansen J A
Effects of treatment regimens on post marrow transplant relapse.
Seminars in hematology 1991;28(3 Suppl 4):32-4.
1991: Doney K; Fisher L D; Appelbaum F R; Buckner C D; Storb R; Singer J; Fefer A; Anasetti C; Beatty P; Bensinger W
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
Bone marrow transplantation 1991;7(6):453-9.
1991: Anasetti C; Martin P J; Storb R; Appelbaum F R; Beatty P G; Calori E; Davis J; Doney K; Reichert T; Stewart P
Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3.
Bone marrow transplantation 1991;7(5):375-81.
1991: Nemunaitis J; Buckner C D; Appelbaum F R; Higano C S; Mori M; Bianco J; Epstein C; Lipani J; Hansen J; Storb R
Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation.
Blood 1991;77(9):2065-71.
1991: deGast G C; Beatty P G; Amos D; Mickelson E M; Sullivan K M; Anderson J E; Giblett E R; Appelbaum F; Storb R; Deeg H J
Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease.
Bone marrow transplantation 1991;7(4):293-5.
1991: Martin P J; Schoch G; Fisher L; Byers V; Appelbaum F R; McDonald G B; Storb R; Hansen J A
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.
Blood 1991;77(8):1821-8.
1991: Clift R A; Buckner C D; Appelbaum F R; Bryant E; Bearman S I; Petersen F B; Fisher L D; Anasetti C; Beatty P; Bensinger W I
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens.
Blood 1991;77(8):1660-5.
1991: Press O W; Livingston R; Mortimer J; Collins C; Appelbaum F
Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(3):423-31.
1991: Sandmaier B M; Schuening F G; Bianco J A; Rosenman S J; Bernstein I; Goehle S; Storb R; Appelbaum F R
Biochemical characterization of a unique canine myeloid antigen.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(2):125-30.
1991: Storb R; Bean M A; Appelbaum F R; Schuening F G; Graham T C; Raff R F
Treatment of marrow donor blood products with gamma-irradiation prevents transfusion-induced sensitization to DLA-identical marrow grafts.
Transplantation proceedings 1991;23(1 Pt 2):1697-8.
1991: Nemunaitis J; Singer J W; Buckner C D; Mori T; Laponi J; Hill R; Storb R; Sullivan K M; Hansen J A; Appelbaum F R
Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy.
Bone marrow transplantation 1991;7(1):49-52.
1991: Buckner C D; Clift R A; Appelbaum F R; Storb R; Petersen F B; Sanders J E; Thomas E D; Hansen J A
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
Bone marrow transplantation 1991;7 Suppl 2():6-8.
1991: Press O W; Eary J F; Badger C C; Martin P J; Appelbaum F R; Nelp W B; Levy R; Miller R; Fisher D; Matthews D
Radiolabeled antibody therapy of human B cell lymphomas.
Advances in experimental medicine and biology 1991;303():91-6.
1990: Clift R A; Buckner C D; Appelbaum F R; Bearman S I; Petersen F B; Fisher L D; Anasetti C; Beatty P; Bensinger W I; Doney K
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.
Blood 1990;76(9):1867-71.
1990: Loughran T P; Raff R F; Graham T C; Appelbaum F R; Schuening F G; Sale G E; Storb R
Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts.
Experimental hematology 1990;18(10):1126-31.
1990: Martin P J; Schoch G; Fisher L; Byers V; Anasetti C; Appelbaum F R; Beatty P G; Doney K; McDonald G B; Sanders J E
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.
Blood 1990;76(8):1464-72.
1990: Storb R; Pepe M; Anasetti C; Appelbaum F R; Beatty P; Doney K; Martin P; Stewart P; Sullivan K M; Witherspoon R
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
Blood 1990;76(5):1037-45.
1990: Radich J P; Kopecky K J; Willman C L; Weick J; Head D; Appelbaum F; Collins S J
N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.
Blood 1990;76(4):801-7.
1990: Sandmaier B M; Storb R; Appelbaum F R; Gallatin W M
An antibody that facilitates hematopoietic engraftment recognizes CD44.
Blood 1990;76(3):630-5.
1990: Schuening F G; Storb R; Goehle S; Graham T C; Hackman R; Mori M; Souza L M; Appelbaum F R
Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
Blood 1990;76(3):636-40.
1990: Anasetti C; Martin P J; Hansen J A; Appelbaum F R; Beatty P G; Doney K; Harkonen S; Jackson A; Reichert T; Stewart P
A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease.
Transplantation 1990;50(1):49-54.
1990: Appelbaum F R
Introduction and overview of interferon alfa in myeloproliferative and hemangiomatous diseases.
Seminars in hematology 1990;27(3 Suppl 4):1-5.
1990: Nemunaitis J; Singer J W; Buckner C D; Durnam D; Epstein C; Hill R; Storb R; Thomas E D; Appelbaum F R
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation.
Blood 1990;76(1):245-53.
1990: Storb R; Appelbaum F; Buckner C D; Clift R; Anasetti C; Beatty P; Bianco J; Doney K; Hansen J; Martin P
HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
Bone marrow transplantation 1990;6 Suppl 1():80-4.
1990: Storb R; Appelbaum F; Nemunaitis J; Schuening F; Singer J; Epstein C; Buckner C D; Souza L M; Thomas E D
Hematopoietic growth factors in marrow transplantation and radiation injury.
Bone marrow transplantation 1990;6 Suppl 1():116-20.
1990: Sullivan K M; Appelbaum F R
Comparative trials of chemotherapy and bone marrow transplantation in acute nonlymphocytic leukemia.
[Rinsho ketsueki] The Japanese journal of clinical hematology 1990;31(5):527-33.
1990: Petersen F B; Appelbaum F R; Hill R; Fisher L D; Bigelow C L; Sanders J E; Sullivan K M; Bensinger W I; Witherspoon R P; Storb R
Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(4):638-47.
1990: Appelbaum F R; Barrall J; Storb R; Fisher L D; Schoch G; Ramberg R E; Shulman H; Anasetti C; Bearman S I; Beatty P
Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.
Annals of internal medicine 1990;112(8):590-7.
1990: Bianco J A; Appelbaum F R
Biotherapy after marrow transplantation and the use of hematopoietic growth factors.
Current opinion in oncology 1990;2(2):289-96.
1990: Bearman S I; Petersen F B; Schor R A; Denney J D; Fisher L D; Appelbaum F R; Buckner C D
Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity.
Bone marrow transplantation 1990;5(3):173-7.
1990: Ladiges W C; Storb R; Raff R F; Appelbaum F R; Sandmaier B; Schuening F; Graham T
Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients.
Bone marrow transplantation 1990;5(1):43-6.
1990: Press O W; Eary J F; Badger C C; Martin P J; Appelbaum F R; Nelp W B; Krohn K A; Fisher D; Porter B; Thomas E D
High-dose radioimmunotherapy of B cell lymphomas.
Frontiers of radiation therapy and oncology 1990;24():204-13; discussion 225-7.
1990: Appelbaum F R; Nemunaitis J; Singer J W; Buckner C D; Storb R; Thomas E D
Use of recombinant human granulocyte macrophage colony-stimulating factor to speed engraftment and treat graft failure following marrow transplantation in man.
Haematology and blood transfusion 1990;33():736-40.
1990: Storb R; Buckner C D; Clift R A; Appelbaum F R; Doney K C; Martin P; Anasetti C; Hansen J; Sanders J E; Petersen F B
Marrow grafting for acute leukemia: results and future treatment strategies.
Haematology and blood transfusion 1990;33():629-35.
1990: Sullivan K M; Meyers J; Petersen F B; Bowden R; Counts G C; Banaji M; Schubert M; Clark J; Clift R A; Appelbaum F R
Supportive care of the marrow transplant recipient: the Seattle Experience.
Haematology and blood transfusion 1990;33():539-45.
1989: Petersen F B; Buckner C D; Appelbaum F R; Clift R A; Sanders J E; Bensinger W I; Storb R; Witherspoon R P; Sullivan K M; Bearman S I
Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
Bone marrow transplantation 1989;4(6):617-23.
1989: Bianco J A; Sandmaier B; Brown P A; Badger C; Bernstein I; Eary J; Durack L; Schuening F; Storb R; Appelbaum F
Specific marrow localization of an 131I-labeled anti-myeloid antibody in normal dogs: effects of a "cold" antibody pretreatment dose on marrow localization.
Experimental hematology 1989;17(9):929-34.
1989: Appelbaum F R
Marrow transplantation in the treatment of patients with lymphoma.
Current opinion in oncology 1989;1(1):47-54.
1989: Petersen F B; Appelbaum F R; Bigelow C L; Buckner C D; Clift R A; Sanders J E; Storb R; Sullivan K M; Weiden P L; Fefer A
High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.
Bone marrow transplantation 1989;4(5):483-8.
1989: Bearman S I; Appelbaum F R; Back A; Petersen F B; Buckner C D; Sullivan K M; Schoch H G; Fisher L D; Thomas E D
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(9):1288-94.
1989: Schuening F G; Storb R; Goehle S; Nash R; Graham T C; Appelbaum F R; Hackman R; Sandmaier B M; Urdal D L
Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor.
Experimental hematology 1989;17(8):889-94.
1989: Schuening F G; Storb R; Goehle S; Graham T C; Appelbaum F R; Hackman R; Souza L M
Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation.
Blood 1989;74(4):1308-13.
1989: Storb R; Deeg H J; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner C D; Clift R; Hansen J
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
British journal of haematology 1989;72(4):567-72.
1989: Press O W; Eary J F; Badger C C; Martin P J; Appelbaum F R; Levy R; Miller R; Brown S; Nelp W B; Krohn K A
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1027-38.
1989: Storb R; Raff R F; Appelbaum F R; Graham T C; Schuening F G; Sale G; Pepe M
Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts.
Blood 1989;74(3):1139-43.
1989: Appelbaum F R; Raff R F; Storb R; Deeg H J; Graham T C; Sandmaier B; Schuening F
Use of trimetrexate for the prevention of graft-versus-host disease.
Bone marrow transplantation 1989;4(4):421-4.
1989: Appelbaum F R
The clinical use of hematopoietic growth factors.
Seminars in hematology 1989;26(3 Suppl 3):7-14.
1989: Appelbaum F R; Brown P; Sandmaier B; Badger C; Schuening F; Graham T; Storb R
Antibody-radionuclide conjugates as part of a myeloablative preparative regimen for marrow transplantation.
Blood 1989;73(8):2202-8.
1989: Storb R; Deeg H J; Pepe M; Appelbaum F; Anasetti C; Beatty P; Bensinger W; Berenson R; Buckner C D; Clift R
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.
Blood 1989;73(6):1729-34.
1989: Sullivan K M; Weiden P L; Storb R; Witherspoon R P; Fefer A; Fisher L; Buckner C D; Anasetti C; Appelbaum F R; Badger C
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.
Blood 1989;73(6):1720-8.
1989: Sullivan K M; Storb R; Buckner C D; Fefer A; Fisher L; Weiden P L; Witherspoon R P; Appelbaum F R; Banaji M; Hansen J
Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.
The New England journal of medicine 1989;320(13):828-34.
1989: Tallman M S; Kopecky K J; Amos D; Dahlberg S; Hewlett J S; Files J C; Coltman C A; Thomas E D; Appelbaum F R
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(3):326-37.
1989: Buckner C D; Sanders J; Appelbaum F R
Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse.
Bone marrow transplantation 1989;4 Suppl 1():244-6.
1989: Hill R S; Mazza P; Amos D; Buckner C D; Appelbaum F R; Martin P; Still B J; Sica S; Berenson R; Bensinger W
Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation.
Bone marrow transplantation 1989;4(1):69-74.
1989: Anasetti C; Amos D; Beatty P G; Appelbaum F R; Bensinger W; Buckner C D; Clift R; Doney K; Martin P J; Mickelson E
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.
The New England journal of medicine 1989;320(4):197-204.
1989: Mortimer J; Blinder M A; Schulman S; Appelbaum F R; Buckner C D; Clift R A; Sanders J E; Storb R; Thomas E D
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(1):50-7.
1989: Sullivan K M; Buckner C D; Sanders J E; Anasetti C; Appelbaum F R; Clark J; Doney K; Meyers J; Sale G; Storb R
Long-term complications of bone marrow transplantation.
Progress in clinical and biological research 1989;309():367-74.
1988: Martin P J; Clift R A; Fisher L D; Buckner C D; Hansen J A; Appelbaum F R; Doney K C; Sullivan K M; Witherspoon R P; Storb R
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration.
Blood 1988;72(6):1978-84.
1988: Petersen F B; Appelbaum F R; Buckner C D; Sanders J E; Clift R A; McGuffin R; Bearman S I; Flournoy N; Thomas E D
Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy.
Bone marrow transplantation 1988;3(6):619-24.
1988: Raff R F; Severns E; Storb R; Martin P; Graham T; Sandmaier B; Schuening F; Sale G; Appelbaum F R
L-leucyl-L-leucine methyl ester treatment of canine marrow and peripheral blood cells. Inhibition of proliferative responses with maintenance of the capacity for autologous marrow engraftment.
Transplantation 1988;46(5):655-60.
1988: Bearman S I; Appelbaum F R; Buckner C D; Petersen F B; Fisher L D; Clift R A; Thomas E D
Regimen-related toxicity in patients undergoing bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(10):1562-8.
1988: Storb R; Raff R F; Appelbaum F R; Schuening F W; Sandmaier B M; Graham T C; Thomas E D
What radiation dose for DLA-identical canine marrow grafts?
Blood 1988;72(4):1300-4.
1988: Appelbaum F R
Intensive chemotherapy or chemoradiotherapy with autologous marrow support as treatment for patients with solid tumors.
Hematology/oncology clinics of North America 1988;2(3):345-52.
1988: Deeg H J; Storb R; Longton G; Graham T C; Shulman H M; Appelbaum F; Thomas E D
Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: effects of exposure rate, fraction size, and fractionation interval on acute and delayed toxicity.
International journal of radiation oncology, biology, physics 1988;15(3):647-53.
1988: Appelbaum F R; Nemunaitis J
Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) following autologous marrow transplantation in man.
Behring Institute Mitteilungen 1988;(83):145-8.
1988: Storb R; Raff R F; Appelbaum F R; Schuening F W; Sandmaier B M; Graham T C
The influence of transfusions from unrelated DLA-matched or mismatched donors upon marrow grafts between DLA-identical canine littermates.
Transplantation 1988;46(2):334-6.
1988: Nemunaitis J; Singer J W; Buckner C D; Hill R; Storb R; Thomas E D; Appelbaum F R
Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.
Blood 1988;72(2):834-6.
1988: Sullivan K M; Witherspoon R P; Storb R; Deeg H J; Dahlberg S; Sanders J E; Appelbaum F R; Doney K C; Weiden P; Anasetti C
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.
Blood 1988;72(2):555-61.
1988: Sullivan K M; Witherspoon R P; Storb R; Weiden P; Flournoy N; Dahlberg S; Deeg H J; Sanders J E; Doney K C; Appelbaum F R
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.
Blood 1988;72(2):546-54.
1988: Appelbaum F R; Fisher L D; Thomas E D
Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up.
Blood 1988;72(1):179-84.
1988: Appelbaum F R
Marrow transplantation for hematologic malignancies: a brief review of current status and future prospects.
Seminars in hematology 1988;25(3 Suppl 3):16-22.
1988: Ladiges W C; Keast M; Appelbaum F; Storb R
Phenotypic characterization of canine lymphoma, using monoclonal antibodies and a microlymphocytotoxicity assay.
American journal of veterinary research 1988;49(6):870-2.
1988: Sanders J E; Buckner C D; Amos D; Levy W; Appelbaum F R; Doney K; Storb R; Sullivan K M; Witherspoon R P; Thomas E D
Ovarian function following marrow transplantation for aplastic anemia or leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(5):813-8.
1988: Appelbaum F R
Reply to Z. Arlin "Bone marrow transplantation for chronic myelogenous leukemia: some thoughts about future prospects".
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1988;2(4):251-2.
1988: Tallman M S; Nemunaitis J J; McGuire T R; Yee G C; Hughes T E; Almgren J D; Appelbaum F R; Higano C S; McGuffin R W; Singer J W
Comparison of two intravenous cyclosporine infusion schedules in marrow transplant recipients.
Transplantation 1988;45(4):810-3.
1988: Riddell S; Appelbaum F R; Buckner C D; Stewart P; Clift R; Sanders J; Storb R; Sullivan K; Thomas E D
High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(4):576-82.
1988: Deeg H J; Aprile J; Storb R; Graham T C; Hackman R; Appelbaum F R; Schuening F
Functional dendritic cells are required for transfusion-induced sensitization in canine marrow graft recipients.
Blood 1988;71(4):1138-40.
1988: Appelbaum F R; Graham T; Sandmaier B; Schuening F; Storb R
Sensitivity of newly transplanted marrow to further irradiation.
Transplantation 1988;45(4):813-4.
1988: Storb R; Deeg H J; Fisher L; Appelbaum F; Buckner C D; Bensinger W; Clift R; Doney K; Irle C; McGuffin R
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.
Blood 1988;71(2):293-8.
1988: Storb R; Raff R F; Appelbaum F R; Schuening F; Sandmaier B; Shulman H; Deeg H J; Graham T
Failure of antithymocyte serum postgrafting to overcome "resistance" to DLA-nonidentical canine marrow grafts.
Transplantation 1988;45(1):236-9.
1988: Sanders J E; Buckner C D; Clift R A; Fefer A; McGuffin R; Storb R; Appelbaum F; Bensinger W; Beatty P; Doney K
Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation.
Bone marrow transplantation 1988;3(1):11-9.
1988: Sanders J E; Buckner C D; Sullivan K M; Doney K; Appelbaum F; Witherspoon R; Storb R; Thomas E D
Growth and development in children after bone marrow transplantation.
Hormone research 1988;30(2-3):92-7.
1987: Doney K; Buckner C D; Kopecky K J; Sanders J E; Appelbaum F R; Clift R; Sullivan K; Witherspoon R; Storb R; Thomas E D
Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission.
Bone marrow transplantation 1987;2(4):355-63.
1987: Storb R; Deeg H J; Appelbaum F R; Schuening F W; Raff R F; Graham T C
The biology of graft rejection in a canine model of marrow transplantation.
Transplantation proceedings 1987;19(6 Suppl 7):18-22.
1987: Appelbaum F R; Barrall J; Storb R; Ramberg R; Doney K; Sale G E; Thomas E D
Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia.
Experimental hematology 1987;15(11):1134-9.
1987: Meyers J D; Flournoy N; Sanders J E; McGuffin R W; Newton B A; Fisher L D; Lum L G; Appelbaum F R; Doney K; Sullivan K M
Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation.
Annals of internal medicine 1987;107(6):809-16.
1987: Sale G E; Rajantie J; Doney K; Appelbaum F R; Storb R; Thomas E D
Does histologic grading of inflammation in bone marrow predict the response of aplastic anaemia patients to antithymocyte globulin therapy?
British journal of haematology 1987;67(3):261-6.
1987: Schuening F; Storb R; Goehle S; Meyer J; Graham T C; Deeg H J; Appelbaum F R; Sale G E; Graf L; Loughran T P
Facilitation of engraftment of DLA-nonidentical marrow by treatment of recipients with monoclonal antibody directed against marrow cells surviving radiation.
Transplantation 1987;44(5):607-13.
1987: Clift R A; Buckner C D; Thomas E D; Kopecky K J; Appelbaum F R; Tallman M; Storb R; Sanders J; Sullivan K; Banaji M
The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation.
Bone marrow transplantation 1987;2(3):243-58.
1987: Appelbaum F R
Marrow transplantation for malignant lymphoma.
Bone marrow transplantation 1987;2(3):227-31.
1987: Tallman M S; Appelbaum F R; Amos D; Goldberg R S; Livingston R B; Mortimer J; Weiden P L; Thomas E D
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(6):918-26.
1987: Dulley F L; Kanfer E J; Appelbaum F R; Amos D; Hill R S; Buckner C D; Shulman H M; McDonald G B; Thomas E D
Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation.
Transplantation 1987;43(6):870-3.
1987: Kanfer E J; Buckner C D; Fefer A; Storb R; Appelbaum F R; Hill R S; Amos D; Doney K C; Clift R A; Shulman H M
Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
Bone marrow transplantation 1987;1(4):339-46.
1987: Doney K; Storb R; Buckner C D; McGuffin R; Witherspoon R; Deeg H J; Appelbaum F R; Sullivan K M; Thomas E D
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.
Experimental hematology 1987;15(3):239-42.
1987: Kanfer E J; Petersen F B; Buckner C D; Stewart P; Storb R; Hill R S; Appelbaum F R; Clift R A; Doney K C; Shulman H M
Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy.
Cancer treatment reports 1987;71(1):101-2.
1986: Storb R; Kolb H J; Deeg H J; Weiden P L; Appelbaum F; Graham T C; Thomas E D
Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow.
Bone marrow transplantation 1986;1(2):167-77.
1986: Deeg H J; Sullivan K M; Buckner C D; Storb R; Appelbaum F R; Clift R A; Doney K; Sanders J E; Witherspoon R P; Thomas E D
Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation.
Bone marrow transplantation 1986;1(2):151-7.
1986: Sanders J E; Pritchard S; Mahoney P; Amos D; Buckner C D; Witherspoon R P; Deeg H J; Doney K C; Sullivan K M; Appelbaum F R
Growth and development following marrow transplantation for leukemia.
Blood 1986;68(5):1129-35.
1986: Hill R S; Petersen F B; Storb R; Appelbaum F R; Doney K; Dahlberg S; Ramberg R; Thomas E D
Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease.
Blood 1986;67(3):811-6.
1986: Deeg H J; Aprile J; Graham T C; Appelbaum F R; Storb R
Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs.
Blood 1986;67(2):537-9.
1985: Jin N R; Hill R S; Petersen F B; Buckner C D; Stewart P S; Amos D; Appelbaum F R; Clift R A; Bensinger W I; Sanders J E
Marrow harvesting for autologous marrow transplantation.
Experimental hematology 1985;13(9):879-84.
1985: Storb R; Deeg H J; Thomas E D; Appelbaum F R; Buckner C D; Cheever M A; Clift R A; Doney K C; Flournoy N; Kennedy M S
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease.
Blood 1985;66(3):698-702.
1985: Stewart P; Buckner C D; Bensinger W; Appelbaum F; Fefer A; Clift R; Storb R; Sanders J; Meyers J; Hill R
Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission.
Experimental hematology 1985;13(4):267-72.

Sign-in to see more